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Chronic liver disease, especially non-alcoholic fatty liver disease (NAFLD), is 
affecting increasing number of people worldwide. However, until today the 
progression mechanism of chronic liver disease is not yet fully understood. 
Looking for imaging markers from liver surface is an important step for 
understanding disease progression mechanism and possibly systematically 
monitoring chronic liver disease progression in the future. This thesis presents 
a study of imaging markers from liver surface using different optical 
microscopic techniques. The hypothesis driving the whole study is that hepatic 
microcirculation is a meaningful marker for chronic liver disease, and triggers 
the progression of the disease. Since chronic liver disease is usually composed 
of complex histological spectra, we isolated two important histological spectra 
of chronic liver disease, i.e. fibrosis and steatosis, and searched imaging 
markers from these aspects.  
 
To begin the study, we designed and developed an intra-vital imaging window 
for live imaging of rodent liver. On this animal investigation platform, we 
established a quantitative method to characterize the hepatic microvasculature 
related features during the fibrosis progression and correlated the change of 
features with the staging of the fibrosis. We discovered that the drastic change 
of the hepatic microcirculation took place in the early to middle stage of the 
fibrosis. From the result, we inferred that the microcirculation lesion drove the 
progression of fibrosis by advancing the changes of the other features such as 
collagen accumulation.  
 
In the second part of the work presented in this thesis, we kept on looking for 
structural features of liver surface that related to hepatic fibrosis. Nonlinear 
ii 
 
two photon microscope was used to take images from liver surface of both 
normal rat and fibrotic rat. Five features about the collagen/elastin 
morphology and redox status of hepatocytes were extracted and quantified. 
They were found to be related with the fibrotic status. 
 
The third part of this work is devoted to studying the imaging marker of 
steatosis. We delineated the structural feature changes using the Raman 
micro-spectroscopy, and recognized the dominant role that fatty acid is 
playing in disease progression. We envision the integration of all the imaging 
markers we studied in this thesis and the comparison of the significant onset of 
structural feature change and the microcirculation feature change to further 
prove the hypothesis. 
 
Current thesis work is based mainly on the publication 1 and 2 in the list of 
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Chapter 1 Introduction 
1.1 Motivation 
The liver, as the second largest organ of the body, is indispensable to human 
body because of its synthetic, metabolic and detoxicating functions. Chronic 
liver disease, including its complications (such as liver cirrhosis and liver 
cancer), has become the major cause of mortality and morbidity across the 
world (1, 2). According to the data provided by Centers for Disease Control 
and Prevention, the death from chronic liver disease and liver cancer 
accounted for 2.19% of all deaths in USA in the year of 2011. The report 
published by the European Association for the Study of the Liver in the year 
2013, suggests that approximately 29 million people in EU are suffering from 
the chronic liver disease. Although alcohol consumption, Hepatitis B and C 
virus are still the leading causes for the cirrhosis and liver cancer, 
Non-alcoholic fatty liver disease (NAFLD) is becoming the main driver for 
the increased prevalence of the liver disease due to the increasing incidence of 
metabolic syndrome (3).  
 
Chronic liver disease, known as a disease procedure involving progressive 
destruction and regeneration of liver parenchyma, is still not fully understood 
in terms of its progressing mechanisms. Some researchers agrees to the 
concept that extracellular matrix (ECM) remodeling is a pivotally important 
step because it affects both hepatocytes and sinusoidal cell functions (4, 5). 
Meanwhile, advancing fibrosis, which usually leads to cirrhosis, is the most 
common risk factor of liver cancer and liver failure. Therefore, the 
biochemical cascades that are directly or indirectly linked to fibrogenesis, are 
considered to explain the mechanism of chronic liver disease. Specifically, the 
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fibrogenesis involves mainly the activation of Hepatic stellate cells (HSC) and 
myofibroblast meditated by transforming growth factor–β1 (TGF-β1) and 
other mediators (6). The pathogenesis of fibrosis will be reviewed in the next 
chapter.  
 
However, we believe that chronic liver disease is closely associated with 
hepatic vascular lesion. Liver is unique in dual blood perfusion with both 
portal vein and hepatic artery receiving cardiac output (7). The inflow blood 
from inferent vessels flows through sinusoids, where the metabolic exchange 
with hepatic cells is performed, and then exit the liver through the hepatic vein. 
This structure forms the macrocirculation and microcirculation of the liver. In 
macro-perspective, the hepatic vascular lesion leads to the imbalance between 
the blood inflow and outflow. The imbalance deprives the parenchymal cells 
of proper perfusion by microcirculation and thus leads to atrophy of hepatic 
cells and parenchymal extinction. Because parenchymal extinction would 
deform the microvasculature and aggravate the underperfusion of hepatic cells, 
a positive feedback loop is formed (8, 9) to trigger the progressing of chronic 
liver disease. Besides, microcirculation of the liver is responsible for 
transporting hormones and released cytokines. Our group’s previous discovery 
of switch-like bi-stable transition between two levels of active TGF-β1, 
resulting from the competition between thrombospondin-1 (TSP1) meditated 
activation and Plasmin meditated activation (10), also suggests the importance 
of blood circulation in spatial distribution of regulators in ECM production.  
 
Based on the findings above, we therefore propose a hypothesis that the 
hepatic microcirculation is a meaningful marker for progression of chronic 
liver disease and triggers the disease progression. This hypothesis drives the 
whole thesis study about imaging marker of chronic liver disease. Since 
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chronic liver disease usually encompasses of multiple histological spectra, in 
this study, we focus on three most common spectra: fibrosis and steatosis. 
 
1.2 Objective and specific aims 
The whole study is composed of three parts. Each part focuses on different 
imaging markers. These parts form the three specific aims in this thesis. Each 
aim solves a single scientific problem and constitutes a single chapter in this 
thesis. 
 
1.2.1 Specific Aim 1: To characterize hepatic microcirculation, and 
correlate the feature changes of hepatic microcirculation with 
the liver fibrosis progression 
Hypothesis: hepatic microcirculation is a meaningful marker of chronic liver 
disease, the changes of the microcirculation are correlated with the 
progression of fibrosis. 
 
Studies have proved that hepatic venous pressure gradient (HVPG) has a good 
correlation with the degree of cirrhosis (11). This indicates a relationship 
between hemodynamic features and fibrosis. However, the measurement of 
HVPG is rather invasive and inconvenient to practice. Besides, it takes only 
the pressure gradient as a proxy for hepatic microcirculation. Whether the 
morphological vasculature and dynamic speed of the hepatic microcirculation 
correlate to the hepatic disease progression is not known. Therefore, the study 
is refined to focusing on the relationship between the microcirculation features 
and the progression of fibrosis to answer the question if the fibrosis 




In order to achieve the extraction of both morphological features and dynamic 
features of the hepatic microcirculation, current techniques include in vivo 
fluorescence microscopy (12, 13), laser Doppler flowmetry (14), near-infrared 
spectroscopy (15, 16) and orthogonal polarized spectral imaging (17). 
However these methods are limited either by spatial-temporal resolution or by 
involvement of exogenous contrast agent, which affects liver’s function. Thus 
in this study, we implement an intra-vital microscopic system that combines 
wide-field fluorescence microscope and laser speckle contrast imaging (LSCI) 
technique. With our designed intra-vital imaging window, large volumes of in 
vivo images are acquired. Then a computer-based imaging processing method 
is explored for feature recognition and extraction. By using the 
histopathological score as the ground truth of progression of the fibrosis, the 
correlation between the quantified features and the staging of disease is 
analyzed. We find that the changes of the hepatic microcirculation take place 
in the early to middle stage of disease progression. 
 
1.2.2 Specific Aim 2: To explore liver surface structural features 
that relate to liver fibrosis 
Hypothesis: structural features from the liver surface, including the surface 
ECM and redox status of hepatocytes, are important imaging markers to 
indicate the fibrosis status.  
 
In this section, we describe the acquisition of detailed structural and functional 
information from liver surface at cellular and sub-cellular level using 
nonlinear two photon microscopy. The nonlinear microscopy with intrinsic 
two-photon fluorescence (TPEF) and second harmonic generation (SHG) has 
its advantage in the study of liver in vivo. Firstly, it has deeper imaging 
penetration and less photobleaching compared to confocal microscope. 
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Secondly, TPEF/SHG microscopy has been exploited for qualitative and 
quantitative assessment of liver’s histopathology features (18) because of its 
ability to visualize collagen and hepatocytes.  
 
Applying TPEF/SHG microscopy to in vivo liver study enables us to visualize 
the intrinsic components such as reduced pyridine nucleotide (NADPH), 
flavins and collagen type I&III. In this part of study, we use three detection 
channels (i.e. 390-410nm, 430-490nm, 500-560nm) to collect the signal of 
liver of live animal. The images from both capsular and subcapsular layers are 
compared and analyzed quantitatively. Five features are defined that have 
significant difference between normal and fibrotic animal. These features are 
useful imaging markers of liver fibrosis. 
 
1.2.3 Specific Aim 3: To delineate structural and biochemical 
features that relate to hepatic steatosis  
Hypothesis: the structural and biochemical feature changes during the 
progression of steatosis can be studied by Raman micro-spectroscopy.  
 
The steatosis is the main histological spectrum of non-alcoholic fatty liver 
disease (NAFLD). While NAFLD has become the main driver for the 
increased prevalence of chronic liver disease worldwide, more and more 
studies have focused on the progression of NAFLD. Yet the mechanism of the 
progression of NAFLD is not fully understood. In this part, the structural and 
biochemical feature changes during the NAFLD progression is studied using 
Raman micro-spectroscopy. The dominant role of fatty acid accumulation 
during the NAFLD progression is demonstrated. This study helps us better 




1.3 Outline of the whole thesis 
This thesis contains six chapters. The introduction part in the Chapter 1 briefly 
describes the motivation and the objectives of the whole thesis study. In 
Chapter 2, we review the background of the study. It starts with the 
pathogenesis of hepatic fibrosis and NAFLD, followed by a brief review of the 
diagnostic methods of liver disease. Thereafter, the optical microscopic 
techniques used in this thesis, specifically laser speckle contrast techniques, 
non-linear two photon microscope and Raman spectroscope, are reviewed in 
terms of the basic principle and application in bio-imaging. Chapter 3 begins 
with the design and development of liver imaging window of rodents and 
describes the establishment and verification of the method for liver surface 
microcirculation study. In Chapter 4, we explore the surface structural features 
of liver using nonlinear two-photon microscope. In Chapter 5, we delineate the 
structural and biochemical features during the steatosis progression using 
Raman spectroscope. Finally, in Chapter 6, we conclude all the major findings 
of the studies and the implications.  
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Chapter 2 Background and Significance 
In this chapter, we introduce the background information that supports the 
rationale of the work presented in this thesis. Section 2.1 is a brief review of 
chronic liver disease including liver fibrosis and non-alcoholic fatty liver 
disease (NAFLD), and their pathogenesis. The clinical diagnostic method is 
also briefly reviewed at the end. Section 2.2 is about features of liver surface 
that could potentially be imaging markers to monitor chronic liver disease. 
Section 2.3 gives a brief review about different optical microscopic techniques 
used in this thesis. 
 
2.1 Pathogenesis and diagnosis of chronic liver disease 
2.1.1 Liver—anatomy and physiology 
Liver is the second largest organs in body. This vital organ has a wide range of 
functions. In terms of metabolism, liver is functioning by storing glycogen, red 
blood cells decomposition, synthesizing plasma protein, producing hormone 
and detoxificating. Besides, it produces bile, an alkaline compound that aids in 
digestion. It also regulates a large variety of biochemical reactions, including 
the synthesis and breakdown of small and complex molecules. The function of 
liver is irreplaceable for a living body, clinically there is no way to compensate 
for the absence of liver function in the long term (19). 
 
In terms of anatomy, liver has a reddish brown color. The mass is divided in to 
lobes, while the number and size varies with species. For human beings, the 
liver contains four lobes with unequal size and shape. The liver usually lies to 
the right of the stomach and over the gallbladder (rat does not has gallbladder). 
The typical drawing of a rat liver that contains typical four lobes (Middle lobe, 
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Figure 2-1. The anatomy of rat liver, the drawing shows multiple liver lobes and the 
drainage system of the liver. The drainage system includes portal vein (blue), hepatic 
artery (red) and biliary duct (yellow). ML: Middle lobe; LLL: Left lateral lobe; RLL: 
Right lateral lobe; CL: Caudate lobe; CP: Caudate process. Source: Image adapted 
from published literature (20). 
 
Liver is covered by a thin sheet of connective capsule that extends throughout 
the substance of the liver. The connective tissue tree provides support 
scaffolding and helps the blood vessels, lymphatic vessels and the bile ducts to 
traverse the liver. Liver is composed of small units called lobules (Figure 2-2), 
which is the unit structure of the liver. Most livers have between 50,000 and 
100,000 lobules. Each lobule has a hexagonal shape, the arrangement of 
hepatocytes radiates outward from a central vein in the center, with portal 
tracts distributed at the vertices of the lobule (21). Liver cells grouped into 
sheets or bundles surrounded by sinusoids. Sinusoid acts as caterpillar in liver 
and gives liver the ability to hold large amount of blood. This structure also 





Figure 2-2. The microanatomy structure of liver. The liver is composed of hexagonal 
microstructures called liver lobule. Liver cells is grouped into sheets and groups 
surrounded by sinusoids. Source: image adapted from published literature (22) 
 
2.1.2 Hepatic fibrosis and cirrhosis 
Liver fibrosis is a wound-healing process in response to chronic liver injuries 
(23). This process involves mainly the accumulation of scar tissue that consists 
of extracellular matrix (ECM) components. This is a significant characteristic 
of most types of chronic liver disease, such as chronic Hepatitis C virus (HCV) 
infection, alcohol abuse, and nonalcoholic steatohepatitis (NASH). The 
accumulation of ECM will distort the hepatic architecture, which is a 
prominent sign for pathologist to diagnose fibrosis. The subsequent 
development of fibrosis and the presence of nodules of regenerating 
hepatocytes define the cirrhosis. Cirrhosis is commonly featured by cellular 
dysfunction and increased intrahepatic resistance to blood flow (6, 24).  
 
The progression of fibrosis is usually insidious. In most cases, the morbidity 
and mortality occur well after certain complication has developed, while it is 
already the late stage of fibrosis (i.e. cirrhosis). The progression of fibrosis can 
occurs as slow as many years, but under certain clinical settings, such as 
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repeated episodes of acute alcoholic hepatitis, fulminant hepatitis and fibrotic 
cholestasis with HCV re-infection after liver transplantation (25), fibrosis can 
advance rapidly. Clinical complications of advancing fibrosis include ascites, 
renal failure and variceal bleeding. Fibrosis patients experiencing the 
end-stage cirrhosis (also called decompensated cirrhosis) can expect a short 
survival except when liver transplantation is conducted (26). Patients have a 
much higher risk of developing hepatocellular carcinoma (27), and the 
survival rate is worsen due to the increasing dropout rate while waiting for 
donor (28). Because of these reasons, Cirrhosis and hepatocellular carcinoma 
is among the top ten causes of death worldwide.  
 
Unlike other tissue, liver has remarkable regenerative ability. Once acute liver 
injury occurs, liver is able to regenerate and replace the necrotic and apoptotic 
cells. This process is usually initiated by inflammation, but inflammatory 
response comes along with the deposition of ECM. If the hepatic injury 
persists, the liver’s regeneration eventually fail to catch the speed of ECM 
accumulation, the hepatocytes are finally substituted by the ECM, and 
collagen predominated fibrillar scare is formed. The distribution of such 
fibrous material is dependent on the location and the onset of the liver injury. 
For example, ECM is vastly located around portal tracts if the injury is 
resulted from virus infection and cholestatic disorder; fibrotic tissue is largely 
presented in paricentral and perisinusoidal area if the liver disease is induced 
by alcohol or drug (29).  
 
The activated Hepatic Stellate cells (HSC) are believed to be the main 
producer of ECM (30). In normal liver, hepatic stellate cells reside in the space 
of Disse, and function as the major storage sites of vitamin A in liver. Upon 
injury, HSCs undergo a series of morphological and functional changes, and 
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they are activated and transformed into smooth muscle a–actin positive 
myofibroblast-like cells (i.e. activated HSC). At the same time, it acquires 
contractile, proinflammatory, fibrogenic properties, and loses the vitamin A 
storage function (31). The activated HSCs migrate and aggregate to the 
proinflammatory sites, where both collagenous and non-collagenous ECM 
proteins are secreted. The degradation of the ECM is also controlled by 
activated HSCs, which is particularly important for the reverse of liver fibrosis. 
Other than HSC, myofibroblast is another important cell type with fibrogenic 
potential. Myofibroblasts initiate from small vessels around portal region. Its 
proliferation is stimulated by apoptotic hepatocytes (32). Both myofibroblasts 
and HSCs are fibrogenic when stimulated, but HSCs action mainly in 
pericentral region, myofibroblasts dominates the portal region.  
 
The complex interplay among hepatic cells is illustrated in the following 
diagram (Figure 2-3). The primary injuries, such as hepatitis virus, alcohol and 
fat metabolites firstly target different hepatic cells (mostly hepatocytes) and 
induce their release of Reactive oxygen species (ROS) and different kinds of 
inflammatory cytokines. The inflammatory response is therefore initiated. The 
inflammatory cells then stimulate the activation and proliferation of HSCs. 
Meanwhile, the apoptosis of damaged hepatocytes activate myofibroblasts. 
Both HSCs and myofibroblasts migrate to damaged location and secret fibril 
collagen. But the story is much complicated because both of them could secret 
inflammatory chemokines and control the activity of lymphocytes if the injury 
is persisted. This results in the formation of a vicious circle that both 
inflammation and fibrogenesis stimulate each other to occur (33). The circle 






Figure 2-3. Mechanisms of liver fibrosis. The primary hepatotoxic agents induce 
inflammatory response among hepatic cells through the production of mediators. 
Damaged hepatic cells (hepatocytes and biliary cells) release ROS and inflammatory 
cytokines to activate the Kupffer cells and T cells. The inflammatory cells activated 
the HSCs and other type of myofibroblasts. Activated HSCs secrete cytokines so that 
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to retain the activated status, and to control the activity of the inflammatory cells. In 
the mean time they secret large amount of fibril collagen (ECM) at the damaged 
location to replace the apoptotic hepatic cells. If the injury persist, this circle goes on 
and on till cirrhosis and liver failure. But once the injury ceased, the degradation of 
ECM surpasses the synthesis of ECM, this explains the reversibility of fibrosis. The 
degradation of collagen is induced by the increased activity of matrix 
metalloproteinases (MMPs) and decreased expression of tissue inhibitor of 
metalloproteinases (TIMPs). The reversal of fibrosis also involves the apoptosis of 
activated HSCs and regeneration of hepatocytes. CCL21, C-C chemokine ligand 21; 
MCP-1, monocyte chemoattractant protein–1; MIP-2, macrophage inflammatory 
protein–2; NS3, HCV nonstructural protein 3; NS5, HCV nonstructural protein 5; 
PAF, platelet-activating factor. Source: image adapted from published literature (6)   
 
The premise of forming the vicious circle is persistent injury, but what if the 
injury is suspended? This brings our attention to the most controversial issue 
regarding liver fibrosis: is liver fibrosis reversible? The reversibility issue of 
liver fibrosis is under the spot light in the recent decade (34-36). Since right 
now the only effective treatment for end stage cirrhosis is liver transplantation, 
but in most society, the availability of donor organ has limited the applicability 
of this treatment. Therefore, the possibility of regression of fibrosis has 
become the kernel for developing antifibrotic therapies. 
 
Recent evidence indicates that even advanced fibrosis is reversible, both on 
experimentally induced fibrosis of animal models (37) and on human patients 
(38-41), even though the regression usually takes very long term with the 
condition of withdrawn liver insult. The mechanism of fibrosis regression has 
been extensively discussed in previous literature (37). The family of matrix 
metalloproteinases (MMP), expressed by activated HSCs and Kupffer cells, 
has been believed to have the ability to degrade collagen (type I and III) (42). 
Evidence also indicates that decreased expression of tissue inhibitors of 
metalloproteinases (TIMPs) (43) and the apoptosis of activated HSC (44) also 
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take roles in inhibiting collagenase and stimulating ECM degradation (Figure 
2-3).  
 
2.1.3 NAFLD and NAFLD derived hepatocellular carcinoma  
Non-alcoholic fatty liver disease (NAFLD) is becoming the main driver for 
the increased prevalence of the liver disease due to the increasing incidence of 
metabolic syndrome (45). The pathology of NAFLD resembles 
alcohol-induced liver disease, but involves no alcohol abuse. The most 
obvious hallmark is the accumulation of the triglycerides within hepatocytes, 
and thus characterized by central obesity and metabolic syndrome (MS). It is 
also characterized by insulin resistance (IR), which is a physiological 
condition that cells fail to respond to the normal secretion of hormone insulin. 
Therefore，NAFLD could result in type II diabetes. Besides, NAFLD is a risk 
factor to Hepatocellular Carcinoma (HCC), among the patients with NAFLD, 
around 30% of the population will develop NASH, which is a more serious 
level of liver damage, and around 20% of the patients with NASH eventually 
develop cirrhosis and liver cancer.  
 
Because NAFLD is a completed process that encompasses MS, NASH, 
necroinflamation and advancing fibrosis, it is unclear which contributes the 
most to the final development of HCC, the underlying mechanism among 
them is not well understood. Previous studies hold that cirrhosis is a main risk 
factor for hepatocellular carcinoma, therefore HCC can be regarded as a 
complication of end-stage NAFLD, just like other chronic fibrotic liver 
disease. However more and more evidence (46) indicates that 
hepatocarcinogenesis may be related to early stage of NAFLD so that MS 
might be the real risk factor to HCC (47, 48). Even though patients with 
NAFLD and cirrhosis have the highest risk of developing HCC, patients with 
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NAFLD but without cirrhosis can also develop HCC (49). HCC has been 
discovered in patients with simple steatosis, which is neither NASH nor 
fibrosis (50, 51). 
 
Besides NAFLD, metabolic factors such as obesity and type II diabetes are 
also associated with HCC. Obesity is a problem that attracts enough attention 
in recent decades. Research has shown that obesity increased the risk of many 
cancers especially liver cancer (47). Obesity specifically increases the risk of 
HCC in populations that are already at high risk of HCC, for example with 
cirrhosis (52) and Hepatitis B (53) or Hepatitis C (54). Diabetes mellitus, 
mainly type II, has also been identified as an independent risk factor for HCC 
(55, 56). Diabetes also potentiate the obesity associated risk of HCC (57). 
Therefore, treating NAFLD with insulin-sensitizing drugs improves steatosis 
and inflammation, resulting in a reduced risk of liver cancer (58). 
  
NAFLD is inflammatory dominant disease, and the occurrence of 
inflammation has a close relationship with the fat accumulation. The nuclear 
factor κB (NF-κB) family of transcription factors are the main regulator for 
inflammatory responses (59). In the inactive state, NF-κB proteins are 
suppressed by inhibitor of NF-κB (IκB). IκB kinase (IKK) complex can 
phosphorylate the IκB and target IκB for degradation, thus permitting nuclear 
localization of NF-κB proteins and altering transcription of genes regulated by 
NF-κB. The IKK complex includes two subunits, one is IKK-α and IKK-β, 
the other is NF-κB essential modifier (NEMO) (60). Deregulated activation of 
NF-κB has important effect on the development of NASH, IR, inflammation, 
fibrosis and cancer (61, 62) . The pathways involved in NAFLD- meditated 




Figure 2-4. Overview of the pathway that involves in NAFLD related 
hepatocarcinogenesis. Inside the pink box, there are onco-MicroRNAs (oncoMiRs) 
that ablate expression of tumor suppressor. Inside the green box, there are tumor 
suppressor miRs. Black arrow indicates the activation of downstream signaling. Red 
blunted lines indicates inhibition, bidirectional arrows indicate crosstalk between 
signaling molecules. The red ‘×’ indicates the abrogation of signaling of specific 
molecules. Figure is adapted from reference (63) 
 
2.1.4 Clinical methodology of diagnosis 
The development of chronic liver disease is always insidious in the early stage, 
early detection and treatment is almost impossible. Therefore, diagnosis of 
chronic liver disease is to decide if the disease is progressing and forecast how 
fast it is progressing to the end stage. Currently, liver biopsy and histological 
examination is still the gold-standard method to diagnose liver disease, which 
is trusted by most doctors. The H&E or other specific stained tissue is 
investigated by experienced histologist to identify the cause of the disease and 
to assess the stage of disease. Taking fibrosis for example, diagnosis is based 
on the scoring or staging according to the standard of Metavir score (0-4) (64) 
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or Ishak score (0-6) (65) (Table 2-1). The limitation of liver biopsy is its 
invasive nature and less representativeness of the obtained tissue. There is a 
report that 40% of patients experienced pain and 0.5% of patients went 
through complications come with liver biopsy (66). Besides, the biopsy tissue, 
with the area of 30-50 mm2, is trivial and incurs sampling error. The literature 
has suggested that cirrhosis is misdiagnosed on single liver biopsy in 10%-30% 
of the cases (67).  
 
Table 2-1. Scoring systems of liver fibrosis. The Ishak system has 6 grades; the 






No fibrosis (normal) 0 0 
Fibrous expansion of some portal areas ± short fibrous 
septa 
1 1 




Fibrous expansion of most portal areas with occasional 
portal to portal (P-P) bridging 
3 
Fibrous expansion of portal areas with marked bridging 




Marked bridging (P-P and/or P-C), with occasional 
nodules (incomplete cirrhosis) 
5 
Cirrhosis, probable or definite 6 4 
 
Besides liver biopsy, other non-invasive complementary diagnose method has 
been emerging. Broadly speaking, they can be divided to biological approach, 
including serum markers and metabolic test, and physical approach, including 
bioimaging based on ultrasound, MRI and elastrography. The advantage and 




Table 2-2. The advantages and disadvantages of both invasive and non-invasive 
approaches for liver disease diagnosis. 
 
 
Protein serum can be used to decide liver disease status (68). However, the 
liver disease-specific markers in the blood may reflect disease in organs other 
than liver. Therefore, unless ideal features of liver disease markers are met, 
biomarkers remain questionable in detecting liver disease. The criteria include 
liver specific (independent of metabolic alterations of other organ); be 
sensitive to discriminate different stages of disease; be able to correlate with 
dynamic changes in disease progression and be able to predict clinical 
outcomes including liver failure (69). To date, no biomarker has been really fit 
these criteria well. Besides biomarkers, other non-invasive diagnostic tools are 
also applied to clinical scenario. For example, the diagnosis of liver fibrosis 
can be achieved using ultrasonographic and tomographic technique. Transient 
elastography (FibroScan) is assessing liver fibrosis by measuring liver 
stiffness (70) and it has great potential to detect fibrosis non-invasively (71), 
but it does not provide tissue and cellular level information (72), on which 
major histological diagnoses count. On the other hand, magnetic resonance 
spectroscopy (MRS) has gained great focus on its potential of detecting 
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fibrosis, but it needs to be confirmed in larger studies with standardized 
methods (73). In the long run, the reliable non-invasive or minimum-invasive 
markers and diagnosis of liver disease should have remarkable impact on 
clinical trials and would benefit patients with chronic liver disease. 
 
2.2 Imaging features of liver surface 
Looking for imaging features from the liver surface is meaningful for study of 
liver disease mechanism, and it is also useful for drug screening using animal 
model. When using imaging technique to study liver, the compromise between 
resolution and the penetration depth has to be considered. The application of 
optical microscope in biological study, especially in vivo tissue imaging, is 
largely limited by its penetration depth. Because the penetration limit is 
largely depend on the mean free path (MFP) of a photon. MFP is a parameter 
that describes the average distance a photon travels between two consecutive 
elastic scattering events. The elastic scattering is resulted from the interaction 
between the photon and cellular structures (74). The MFP is usually of the 
order of 100um, varies with the tissue type. Usually the scattering is more 
minimized in near-infrared spectrum than in visible and ultraviolet spectrum. 
Since the investigation performed by optical microscope is quite superficial, in 
this section we therefore focus on the liver surface. We believe components 
within the liver surface are of structural and functional significance, because it 
provides key information about the physiology of the liver. However, since the 
histo-pathological features that are used in routine staging systems 
(METAVIR and Ishak) are mostly derived from the cellular and tissue 
structures in the interior liver and cannot be observed from the liver surface 
using optical microscopic techniques, the correlation between the changes of 




2.2.1 Extracellular matrix 
The progression of fibrosis is featured by the alteration of both the quantity 
and the composition of the ECM. Its quantity change could be as conspicuous 
as 6 times in fibrotic liver more than in normal liver, including collagens (type 
I, III, and IV), fibronectin, undulin and elastin. Therefore it has been an 
important marker for fibrosis diagnosis. Besides ECM that distributed among 
the liver parenchyma, liver surface is covered by a 10 µm collagenous layer 
called the Glisson’s capsule (75). The thickness of the Glisson’s capsule has 
been reported to increase to 17-46 um during fibrosis progression (76) as 
imaged from the biopsied liver tissue sections. Besides, our previous finding 
has demonstrated that collagen proportionate area (CPA) in liver sub-capsule 
region, which is beneath the Glisson’s capsule but is still detectable by optical 
microscope, are consistent with CPA measured from interior liver and are 
well-correlated with fibrosis stages (77). Therefore, ECM investigated from 
the liver surface could be a marker of liver disease.  
 
2.2.2 Autofluorescence of endogenous fluorophores  
The autofluorescence of the hepatic cells could also be an intrinsic marker to 
discriminating normal and diseased status, because autofluorescence 
properties are closely related to the metabolic status of the hepatic cells (78). 
The endogenous fluorophores inside liver include NAD(P)H, flavins, vitamin 
A and fatty acid. Their optimal excitation wavelength and emission peak 
center wavelength of these endogenous fluorophores are listed in Table 2-3. 
The NAD(P)H/flavins, NAD+/NADH and NADP+/NADPH are common 
redox couples, the value of the ratio indicates the cellular redox state. 
Therefore they are markers of the energy production and intermediary 
metabolic status of the hepatocytes. Vitamin A is an antioxidant; it is stored 
inside Hepatic stellate cell (HSC) of liver. In fact, HSC stores 80% of Vitamin 
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A of the whole body as retinyl palmitate (79). HSC plays an important role in 
liver regeneration and lose the storage of vitamin A when it is activated. 
Therefore the detection of vitamin A is important in deciding if the liver is 
injured.  
 
Table 2-3. The optimal excitation wavelength and emission peak center wavelength of 
endogenous fluorophores of liver  
Endogenous 
fluorophores 
Optimal excitation wavelength 
(nm) 
Emission peak center 
wavelength (nm) 
NAD(P)Hfree 366 463 
NAD(P)Hbound 366 444 
Flavins 488 526 
Vitamin A 366 488 
Fatty acid 366 470 
lipopigments 488 587 
 
2.2.3 Hepatic surface microcirculation 
The liver has its unique blood perfusion system: it receives 25% of the cardiac 
output via two inflows, the portal vein and hepatic artery. Both vessels enter 
the liver at its hilus accompanied by the hepatic bile ducts, lymphatics and 
nerves. 75-80% of the total inflow is contributed by the capillary system of the 
intestine, spleen, pancreas and gallbladder via portal vein, the rest 20-25% is 
delivered through the hepatic artery (7). The total hepatic perfusion amounts to 
~1ml.min-1.g tissue -1 and the total oxygen consumption accounts for 20% of 
total body consumption (80). The dual blood supply of the liver distinctly 




The hepatic microvascular bed, particularly the terminal distribution of the 
blood vessels and the sinusoids are as follows. In the portal tracts, branches of 
the hepatic artery, the hepatic portal vein, the main bile duct and the main 
lymphatic vessels travel parallel to each other through the liver parenchyma 
(81). After repeated branching, the terminal vessels transfer the blood to the 
hepatic sinusoids (Figure 2-5). The hepatic sinusoids correspond to the 
capillary bed of the liver and represent the segment of the microcirculation 
where supplying of nutrients and removal of metabolic products take place. 
The sinusoids diameters increase from 7um in the periportal to 15 um in the 
pericentral area, with length of ~250um. The endothelial cells that constitute 
the sinusoids have a special structure called ‘sieve plate’, it is open 
fenestrations ranged in clusters of 10-50 pores with a diameter of 150-175nm 
(82). Sieve plate acts as a selective sieving barrier to control the extensive 
exchange of material between the blood and the liver cells. After flowing 
through the sinusoids, blood passes through outlet, several of such terminal 
central veins may combine, increasing in diameter and reaching the 
sub-lobular vein and hepatic vein. They leave the liver on the dorsal surface 





Figure 2-5. The primary vascular system of liver lobule is composed of portal vein-PV, 
the central vein-CV and the artery-A. After repeated branching, the portal vein and 
artery (zone I) is divided to small sinusoids (Zone II), nutrition/oxygen supply and 
metabolic exchange occur in sinusoids. Sinusoids combine together and converge to 
central vein (zone III).  
 
Hepatic vascular disorder is widely acknowledged as a symptom of chronic 
liver disease. Even though the vascular lesion is commonly regarded as 
secondary to primary injury (such as alcohol abuse, HCV infection and toxic 
exposure), it is detrimental to hepatocytes by relating to provision of nutrients 
and oxygen, which is the main function of hepatic microcirculation system. In 
previous research, the importance of microcirculation lesion has been 
identified in the progression model of chronic liver disease, including 
Nonalcoholic Steatohepatitis (NASH) and alcoholic fatty liver (8, 83).  
 
Once the vascular disorder has been presented, the ischemic injury will result 
in focal collapse of the tissue; when focal collapse accumulates to widespread 
parenchymal extinction, portal tract becomes more close to the adjacent 
hepatic vein. This change offers the opportunity for the artery in the portal 
tract to drain directly into the collapsed perivenous tissue, this is called the 
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arterivenous shunt (84, 85). The shunt formation induces the generation of 
high-flow and high-pressure conduit between artery and vein. Together with 
the bridging fibrous septa between portal tracts and terminal veins, the newly 
formed vascular channel effectively bypasses the parenchymal nodules, and 
leaves the parenchymal tissue bereft of blood flow. The underperfusion of the 
liver parenchyma in turn contributes to more advanced parenchymal extinction, 
thus a positive feedback is formed to impel the disease progression.  
 
2.3 Imaging modality for liver surface imaging 
2.3.1 Laser speckle contrast imaging 
First introduced in the 1980s, laser speckle contrast imaging becomes a 
powerful tool for imaging blood flow. It especially gained much attention in 
recent year because of the application in brain blood flow study (86-88). Laser 
speckle arises from the random interference pattern when coherent light is 
scattered by a random medium. The moving scattering particles inside the 
random medium cause the time-varying phase shift and change the random 
interference pattern, thus the fluctuation of the speckle pattern is produced. 
When recording the fluctuation with the camera, the intensity variation shows 
up at the photodetector. Using temporal and spatial statistics to analyze the 
intensity variation could yield information about the motion of the scattering 
particles. Practically, when applying this technique to blood flow study, the 
increased blood flow speed will cause the intensity of the speckle pattern to 
fluctuate more rapidly, thus when recording within the CCD integral time 
(usually 1 to 20 ms), the speckle becomes much blurred in the corresponding 
area. Therefore, by acquiring the image of the speckle pattern and quantifying 
the blurring of the speckle, the spatial blood flow map could be obtained. To 
quantify the blurring, the speckle contrast is defined as the ratio of the 
standard deviation to the mean intensity:  
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ܭ௦,௧ ൌ ఙೞ,೟ழூவ                         (1) 
Here the ܭ௦ refers to the spatial speckle contrast, ܭ௧ refers to the temporal 
speckle contrast, ߪ௦ indicates the spatial standard deviation of the speckle 
intensity, ߪ௧ indicates the temporal standard deviation of the speckle intensity. 
 
 
Figure 2-6. (a) Raw speckle image from rat’s thinned skull, the grainy pattern is 
showed. (b). the corresponding spatial contrast image computed using a 5×5 window. 
Figure adapted from reference (86).  
 
Figure 2-6 shows the representative raw image and the corresponding 
computed contrast flow map of the rat cortical surface. In theory, the speckle 
contrast has the value between 0 and 1. A speckle contrast of 1 indicates no 
blurring of the speckle pattern and thus no motion of the particles. A speckle 
contrast of 0 indicates that the speckle is blurred because the particles are 
moving fast enough. The speckle contrast is a function of the integral time T 
of the camera and is related to the autocovariance of the intensity fluctuation 
of a single speckle	C୲ሺ߬ሻ by (89)  




଴                  (2) 
The corrected formulation proposed recently is wrote as (90)  
ܭଶ ൌ 	 ఙೞమሺ்ሻழூவ	మ ൌ 	
ଵ
்మழூவమ∬ ܥ௧ሺ߬ െ ߬ ′ሻ݀߬݀߬ ′
்




଴ .  (3) 
The autocovariance is defined as 
ܥሺ߬ሻ ൌ൏ ሾܫሺݐሻ െ൏ ܫ ൐௧ሿሾܫሺݐ ൅ ߬ሻ െ൏ ܫ ൐௧ሿ ൐,      (4) 
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Where <X>t indicates quantity averaged by time. According to dynamic light 
scattering theory, the intensity temporal autocorrelation and the 
autocovariance can also be expressed as (91) 
஼೟ሺఛሻ
ழூவ೟మ
ൌ 	ߚ| ழாሺ௧ሻா∗ሺ௧ାఛሻவழாሺ௧ሻா∗ሺ௧ሻவ |ଶ,                  (5) 
The right side of the equation is the electric field temporal autocorrelation 
function, ߚ accounts for the loss of correlation that has a relationship with the 





ఛ೎ሻ,                (6) 
Therefore, the speckle contrast can be expressed as  







଴.ହ.        (7) 
The speckle contrast is a function of the camera exposure time T and the time 
scale of the sample dynamics ߬௖ which is related to the speed of blood flow. 
Although the values of ܭଶ	are in the range of [0, 1] in theory, they are 
practically limited to [0, 0.1]. ܭଶ therefore degrades into a linear correlation 
with ߬௖ when the contrast is less than 0.1, thus the reciprocal (1/ܭଶ) can be 
used to indicate the relative changes in blood flow. 
 
 
Laser speckle contrast techniques have been applied to a large number of 
blood flow imaging studies such as the retina, skin and brain. These tissues are 
well suited to be studied by this technique because the blood flows are 
superficial and laser speckle contrast techniques cannot access deep tissue. 
Retina is one of the earliest applications of laser speckle, because the 
vasculature is quite accessible. Researches on retina includes the effects of 
pharmacological agents on retina blood flow (93, 94) and analysis of the flow 
around the optic nerve head (95). In recent years, laser speckle contrast 
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techniques have been widely applied in study of blood flow in brain, such as 
to measure the hemodynamic responses to various stimuli (96, 97), 
comparison of normal blood flow with disease blood flow (86). Skin perfusion 
measurement is the most mature clinical application. For example, Huang et al 
have used laser speckle to real-timely monitor the skin response before and 
after the laser therapy of port wine stain birthmark (98).  
 
2.3.2 Two photon excitation and second harmonic generation 
microscopy 
The basic principle of two-photon excitation can be illustrated by Figure 2-7. 
The concept of two-photon excitation is a relatively old theory. It is a 
nonlinear process that involves simultaneous absorption of two photons, with 
their combined energy sufficient to drive a molecular transition to an excited 
electronic state (99). Generally, photons of wavelengths λ1 and λ2 within the 
constraint follow that 
λଵ୮ିଵ ≅ ଵఒభ ൅
ଵ
ఒమ,                        (8) 
where λ1p is the wavelength needed to produce fluorescence emission in a 
one-photon absorption event. Practically since λ1=λ2 , the equation becomes 
ߣଵ ൎ 2ߣଵ௣  (100). This indicates that the excitation wavelength in the 





Figure 2-7. The scheme for one- and two-photon excitation. We take ߣ1݌ ൌ 350݊݉ 
for example. Fluorescent molecule is excited and shift to excited state and later 
relaxes back with emission at 420nm. In the identical two-photon excitation event, 
two photons at 700nm are absorbed simultaneously. The picture is adapted from 
http://www.microscopyu.com. 
 
The interaction between the fluorophores and excitation electromagnetic field 
is the source of the fluorescence excitation. It is described by the 
time-dependent Schröedinger equation, in which the Hamiltonian contains an 
electric dipole interaction term: E, r. Here, E is the electric field vector of the 
photons, r is the position operator. The nth-order solution corresponds to 
n-photon excitation with transition probability P. For two-photon excitation 
process, the probability between the molecular initial state i and the final state 
f is given by: 
P~ฬ∑ ۦ௙|ࡱ∙࢘|୫ۧۦ୫|ࡱ∙࢘|௜ۧகಋିகౣ୫ ฬ
ଶ
,                   (9) 
Where εஓ  is the photon energy associated to the electric field E, the 
summation is over all intermediate states m, ε୫	 is the energy difference 
between the sate m and the ground state. 
 
The occurrence of two-photon excitation depends much on simultaneous 
absorption, which means that both photons interact with the fluorophores at 
the same time (here, ‘the same time’ means a time interval less than 10-18 
seconds). In order to produce significant numbers of two-photon excitation 
events, the photon density must be approximately one million times more than 
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that is required to generate an identical one-photon excitation. This basically 
means extremely high laser power is required to generate significant 
two-photon excitation fluorescence. This has to be achieved by focusing 
mode-locked (pulsed) laser, which produces pulses of light of extremely short 
duration (usually on the order of picoseconds (10-12s) or femtoseconds 
(10-15s)). The power at the peak of the pulse is high enough to generate 
two-photon excitation, but the pulse duty cycle (the duration of the pulse 
divided by the time between the pulses) is on the order of 10-5. Therefore the 
average input power is around 10 mW, which just similar to the power of 
confocal imaging. 
The narrow localization of the two-photon excitation is the basis of the 
technique’s most significant advantages over confocal imaging. In a confocal 
microscope, fluorescence is excited throughout the specimen illuminated 
volume, and a pinhole has to be used to exclude the emission out of the focal 
plane. However, with two-photon excitation microscope, only the fluorescence 
at the focal plane is generated, the photobleaching (and photodamage) of the 
specimen is largely reduced. It also results in the improved axial depth 
discrimination and image contrast. Besides, with this character, study locally 
photo-initiated chemical reaction is feasible. 
 
Practically in biological imaging application, the near IR laser source (relative 
to UV and visible wavelength) renders additional advantage of reduced 
scattering and absorption of excitation photons. In Rayleigh scattering, the 
scattering cross-section is inversely proportional to the fourth power of the 
wavelength. Therefore, the scattering event in the two-photon excitation is 
over an order of magnitude less likely to occur than the one-photon excitation. 
Although Rayleigh scattering is only an approximation of the light 
propagation in biological tissue, the general inverse relationship between 
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scattering and excitation wavelength still exists validly. Most biological tissue 
has reduced absorption in the near IR (refers to as ‘optical window’ at 
700-1000nm), therefore the tissue absorption is much less than the absorption 
in the UV and blue-green region. The reduced scattering and absorption 
explain the deep penetration depth of two-photon excitation microscope.  
 
Finally, compared to conventional one-photon microscope, in which the 
excitation wavelength is close to the emission wavelength, the input 
wavelength is significantly larger than the emission band in two-photon 
excitation microscope. This effectively avoids the cut-off of the emission band 
by the barrier filter which is used to eliminate the leak-through of the 
excitation light. Therefore the unnecessary detection sensitivity reduction is 
avoided. The optical properties of the two photon excitation microscope and 
the benefit derived from these optical properties is listed in Table 2-4. 
 
Table 2-4. The optical properties of the two photon excitation microscope 
 
 
Second-harmonic generation (SHG) was first described in a quartz crystal by 
Franken et al (101). SHG can be viewed as a special case of Sum-frequency 
generation (SFG) that the produced scattered beam is at exactly twice the 
frequency of the input beam. SHG requires that the second order optical 
susceptibility is non-zero, therefore it occurs only in non-centrosymmetric 
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molecules. Its comparison to two-photon excitation is illustrated in the 
Jablonski diagram (Figure 2-8). Unlike two-photon excitation, SHG involves 
no energy lost during relaxation and SHG does not have an excited state. 
Consequently, SHG does not involve excitation of molecules and no 
phototoxicity occurs. The SHG signal is polarization sensitive and its intensity 
depends on the angle between the samples and the polarization of the 
excitation light (102). Since no external labeling of the sample is involved for 
SHG, it can be used to image material with non-centrosymetric organization 
without labelling. Examples of such molecule are protein fibers such as 
collagen, microtubules and cellulose in biological application. Application of 
combined SHG and TPEF to conventional laser scanning microscope makes it 
possible to obtain information of multiple moleculars and structural 
constituents in the same sample. 
 
Figure 2-8. The Jablonski diagram illustrating the difference of SHG and TPEF. SHG: 
two photons are converted to a single photon with twice the energy (half of the 
wavelength). TPEF: two photons are absorbed simultaneously to excite a molecular 
energy state that can emit fluorescence. 
 
The discussion of the principle of SHG has to start from the Maxwell’s wave 








ப୲మ ,                           (10) 
Where E is the electric field vector of the electromagnetic field and PNL is the 
polarization vector. As we are only interested in second order nonlinear effects, 
with ignoring the higher order terms and assuming the electromagnetic waves 
plane waves propagating in the z direction, we simplify the electric field E to 
one consisting only the three infinite uniform plane waves and ignoring the 
effects of double refraction and focusing. It therefore can be written in the 
form: 
Ej(z,t) = Ej(z)݁ି௜௪ೕ௧+c.c.=Aj(z)݁௜ሺ௞ೕ௭ି௪ೕ௧ሻ +c.c.          (11) 
Where j = 1,2, with w1=w, w2=2w, Ej is the complex amplitude of field j, Aj is 
the spatially slowly varying field amplitude and c.c. represents the complex 
conjugate. Besides, there is also 
P2(z,t) = P2(z)݁ଶగሺ௞భ௭ି௪ሻ +c.c.,                (12) 
where P2 represents the complex amplitude of the nonlinear polarization. 





ሺଶሻܣଵଶ݁௜ሺଶ௞భି௞మሻ௭.                 (13) 
Assuming A1 to be constant, the amplitude of the second harmonic field after 





௜∆௞௅ ,                  (14) 




ሺଶሻ൧ଶܫଵଶܮଶ ቂݏ݅݊ܿଶ ቀ௱௞௅ଶ ቁቃ.         (15) 
Only the interactions with ߂݇ = 0 will undergo macroscopic amplifications as 
they propagate through the medium. Even though the second order nonlinear 
susceptibility (non-centrosymmetric medium) is satisfied, nonlinear emission 
dipoles aligned in an anti-parallel arrangement that produce SHG exactly out 





TPEF and SHG have been widely applied to biomedical research. Its 
capability of deep imaging is especially valuable for in vivo imaging (103). 
The in vivo applications include imaging of brain, where a cranial window is 
used on the thinned skull of living animals (104-106); mammalian embryos 
(107-109) and retina(110, 111). The application to in vivo liver study started 
from recent year. For example, Thorling et al. used two-photon microscopy to 
visualize zonal damage after the hepatic ischemia-reperfusion injury (Figure 
2-9) (112) . The same group has also studied drug distribution and metabolism 
in the live rat liver using two-photon microscopy (113). 
 
Figure 2-9. Two-photon microscopy images of liver in vivo after 
ischemia-reperfusion injury at various reperfusion time points. Figure adapted from 
reference (112). 
 
2.3.3 Raman spectroscopy 
Raman spectroscopy is an invaluable technique for investigation of molecules. 
It involves shinning the monochromatic laser light on a sample and detecting 
the inelastic scattered light. The inelastic scattering means that the frequency 
of the monochromatic photons shifts (up or down) upon interaction with the 
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samples. It is also called the Raman effect. The basic origins of Raman effect 
is illustrate as below. 
 
The molecular deformations in electric field E is determined by molecular 
polarizability α. The laser beam forms an oscillating electromagnetic field 
with electrical vector E. Upon interaction with the sample molecules, it 
induces electric dipole moment P =αE, which deforms molecules. With 
periodic deformation, the molecules start vibrating with the characteristic 
frequency νm. The amplitude of vibration is called a nuclear displacement. The 
emission light from the oscillating dipoles has three different frequencies 
(Figure 2-10): 
1. A molecule with no Raman-active modes absorbs a photon with the frequency ν0. 
The excited molecule returns back to the same basic vibrational state and emits 
light with the same frequency ν0. This type of interaction is called an elastic 
Rayleigh scattering. 
2. A molecule with Raman-active mode absorbs a photon with the frequency ν0. 
Parts of the energy is transferred to the Raman-active mode with frequency νm, 
therefore the resulting scattered light has the frequency of ν0-νm. This type of 
interaction is called inelastic Stokes Raman scattering. 
3. A molecule with Raman-active mode absorbs a photon with the frequency ν0. The 
molecule is already in the excited vibrational state, excessive energy of the 
excited Raman active mode with the frequency νm is released. Molecule returns to 
the basic vibrational state and the frequency of the scattered light goes up to 




Figure 2-10. Vibrational energy level diagram showing Rayleigh and Raman 
scattering. 
 
Raman microscope is used in many fields where non-destructive microscopic 
chemical analysis and imaging is required. Both Biologists and Chemists use 
Raman Spectroscopy to identify chemical compounds, their functional groups, 
and to determine the conformation of complex biomolecules, such as proteins 
and DNA. It can be used to rapidly characterize the chemical composition and 
structure of a sample, whether solid, liquid, gas, gel, slurry or powder. It is 
particularly amenable to in vivo measurements. 
 
In the study of biological tissue sample, the Raman spectroscopy has 
advantages over fluorescence microscopy as it requires no external labeling. 
The contrast is generated in the cross section of Raman scattering due to 
induced polarizability generated in the tissue. Near-IR excited Raman 
spectroscopy was discovered to have advantages in studying biological tissue 
in 1986 (114), because with IR excitation, Raman spectra can be measured 
when previously they are immeasurable due to fluorescence interference. The 
features of near IR Raman spectroscopy includes: firstly, the extinction 
coefficients of biological tissues are small at near-IR excitation wavelengths; 
secondly, water is a weaker absorber in the near-IR so that won’t interfere the 
measurement, when biological cells consist of 70-90% of water by weight; 
thirdly, the excitation light at near-IR wavelength is easily transmitted through 
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optical fiber, enabling remote collection of Raman spectra. Near-IR Raman 
spectroscopy has wide application in clinical study. One important application 
is cancer detection. Raman spectroscopy is able to identify markers associated 
with malignant changes. Liu et al. have explored its potential for diagnosing 
malignant lesion in the gynecological tract (115). Shafer-Peltier et al. have 
created a Raman microspectroscopic model of human breast tissue (116). Feld 
et al. used 830nm excited CCD Raman spectroscopy to collect spectra from 
normal and colonic carcinomatous tissues (117). Other applications include 




Chapter 3 Study of Hepatic Microcirculation in Liver 
Fibrosis 
3.1 Introduction  
Hepatic vascular disorder is known as a symptom of chronic liver disease. 
Although commonly regarded as secondary to primary injury (such as alcohol 
abuse, viral hepatitis and toxic exposure), the onset of vascular disorder is 
detrimental to hepatocytes by inhibiting the provision of nutrients and oxygen 
(this is exactly the main function of normal hepatic microcirculation system).  
In previous research, vascular disorder is regarded as critical to the 
progression  of chronic liver disease (especially, NASH and alcoholic fatty 
liver), because once the vascular disorder is presented, ischemic injury comes 
out and leads to focal collapse of the tissue; the accumulated focal collapse 
results in widespread parenchymal extinction (8, 121), which is the omen of 
liver failure and end stage liver disease. Therefore, the prominent importance 
of microcirculation highlighted the need of technical development to detect 
hepatic microvascular abnormalities in vivo.  
 
Several techniques have previously been used to study the hepatic 
microcirculation, including radio/fluorescence labeled microspheres (122), 
hepatic clearance of tracer substances(123, 124), in vivo fluorescence 
microscopy (125, 126) and laser Doppler flowmetry (127, 128). However, 
most techniques are limited by the recruitment of extra contrast-enhancer, such 
as fluorescent dextran and fluorescence labeled red blood cells, because the 
contrast enhancer would introduce undesirable impacts to the liver cells and 
microcirculation (129, 130). Among all the techniques, doppler flowmetry 
technique is label-free but the Doppler signal is easily deteriorated due to 
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phase wrapping and interferometric fringe washout effects, resulting in 
measurement ambiguities and loss of information (131). In the main part of 
this chapter, we describe a methodology of combining wide-field fluorescence 
microscope and laser speckle contrast imaging (LSCI) techniques to study 
liver microcirculation without labeling. 
 
The use of wide-field fluorescence microscope is to take advantage of the 
endogenous fluorophores inside hepatocytes, such as NAD(P)H, flavins inside 
hepatocytes and vitamin A inside hepatic stellate cells (132). Their existences 
give rise to autofluorescence emission, enabling the locating of hepatocytes 
and hepatic stellate cells. LSCI (133) has in recent years attracted considerable 
attention in both laboratory research and clinical application because of its 
advantage in spatiotemporal resolution. It is widely used to monitor capillary 
blood flow (134, 135), image blood coagulation (136), and blood perfusion 
mapping (87, 88, 137). Intensive study on its clinical application has also been 
conducted in skin (138), retina (139, 140) and neurosurgical application 
(141-143). Laser speckle is produced when coherent light is shone onto a 
random medium, and the scattered light is collected by a camera detector. The 
moving particles in the medium, such as red blood cells (RBC) in blood 
vessels, will cause the pattern to fluctuate as a result of time-varying phase 
shifts. Both temporal and spatial intensity variation of the speckle can be 
analyzed to resolve the motion of the scattering particle, i.e. the RBC, and thus 
the information of the blood flow. Practically, the intensity variation is 
quantified as temporal or spatial contrast value. The temporal contrast, mainly 
used in the experiment, is computed through the division between the temporal 
standard deviation and the temporal mean of every pixel. Areas with greater 
motion will render faster intensity fluctuations and therefore more blurred 
speckle within a certain camera exposure time. The contrast thus will be 
39 
 
smaller due to smaller temporal standard deviation of the intensity. A 
combination of the wide-field fluorescence microscope and LSCI will yield a 
complementary function by visualizing both the hepatic parenchymal tissue 
and microcirculation. Neither of each requires the use of external contrast 
agent, endowing this method with good potential of long-term liver disease 
monitoring on animal model. 
 
In this chapter, we start with the design of the intra-vital imaging window, 
followed by the setup of the instrument. To demonstrate the ability of the 
instrument in chacterizing hepatic microcirculation lesion, we create the rat 
primary biliary fibrosis model through Bile Duct Ligation (BDL) surgery. The 
model has been previously investigated regarding both morphological and 
functional changes of liver (144-146), yet studies focus on the relationship 
between microcirculation lesion and the disease progression are rare. Bearing 
the hypothesis that the microcirculation lesion is correlated with the fibrosis 
progression in this fibrosis model, in this chapter, we characterize hepatic 
microcirculation change with progression of fibrosis. We have viewed the 
morphological change and flow speed change of hepatic microcirculation with 
the progression of fibrosis. By further analyzing the obtained digital image 
with imaging processing techniques, we quantify the hepatic microcirculation 
changes, and scrutinize the correlations between its changed features with 
fibrosis progression. This experiment suggests the potential application of this 





3.2 Materials and methods 
3.2.1 Design of Intra-vital imaging window for in vivo imaging of 
liver 
To perform in vivo imaging, intravital hepatic imaging window for rodents 
was modified based on the design of Liu et.al (147). The basic idea for the 
imaging window design is to open a window on the abdomen skin of the 
rodents, exposing the liver but ensuring that the imaging procedure introduces 
little invasion to the abdominal organs. For ease of in vivo imaging, the 
chamber should have the following features:  
1. Easy to be stabilized relative to the microscope, so that the artificial movement 
induced by animals’ heartbeat and breath can be overcame;  
2. Ensure the imaging area is as large as possible but at the same time flat enough to 
facilitate the light penetration.  
 
The prototype of the first generation rat imaging window was illustrated using 
SolidWorks (Dassault Systèmes SolidWorks Corp.) in Figure 3-1(b). In the 
design, all the components can either be locked or screwed to ensure the 
stability. Besides, in practical experiment, we purposely use inverted 
microscope for in vivo imaging, so that the animals are lying on belly facing 
down during the imaging. Their body weight will exert pressure to the liver as 
well as to the window. Therefore the imaging site is less influenced by heart 
beat and breath. In this way the stability is assured. In order to make sure the 
imaging area is large but flat, the diameter size of the window is designed to 
be less than 20mm as shown in Figure 3-1(a) in order to match the actual size 
of the rat liver. The cover slip used together with the imaging chamber is 




Figure 3-1. The first generation of rat liver imaging window. (a) The design and size of 
the inner ring, which is to be installed onto the skin of animal through surgical suturing. 
(b) The assembly diagram, every part can be locked or screwed to ensure stability.  
 
The inner ring of the window is to be sutured to the animal’s abdominal skin, 
the other parts are designed to secure the window to the sample stage of the 
microscope. The design was fabricated with medical grade titanium because 
titanium has good biocompatibility and is used in most implantable medical 
device. The final prototype is showed in Figure 3-2. Figure 3-2(a) shows the 
components designed to secure the window. They include a u-shaped holder to 
lock the window (inner ring), and a ring holder that is attached to the u-shape 
holder and connects all the components to the plate by fitting inside the big 
hole. The plate is shown in Figure 3-2(b). A small screw on the side of the 
plate is used to lock the ring holder. Figure 3-2(c) shows the imaging window 






Figure 3-2. The final prototype of the rat imaging window. (a) The u-shape holder to 
lock the inner window and the ring holder to connect the u-shape holder to the stage.  
(b) The plate that holds the animal. It will be inserted to the microscope sample stage. 
(c) The imaging window with all parts assembled. 
 
Based on our first generation imaging window design, we later improved the 
design with the aim of simplifying the surgical installation procedure. The 
purpose of doing so is to save time for window installation so that we will 
have more time for in vivo imaging. It could also benefit the experiment by 
reducing the usage of anesthetic drug or avoiding the repeating anaesthetizing 
procedure. The second generation window is illustrated in Figure 3-3. In this 
design, the whole window is simplified to three parts. Only the ring to be 
sutured to the skin is fabricated using medical grade titanium, the other parts 






Figure 3-3. The second generation rat imaging window design. The design has been 
simplified to three components. It is handy to use and largely reduces the cost of 
fabrication. 
 
On the basis of our second generation rat imaging window, we revise the 
design to fit on mice because mice are more widely used in study of liver 
cancer than rat because of the availability of genetically-altered mice. 
However, since in all the animal experiment in this thesis, rat is used instead 
of mice, here we only show the design of the mice window chamber, its 
application and evaluation is not included in this thesis. The design of the mice 
imaging window is showed in Figure 3-4. Different from the rat imaging 
window design, in which the plate is directly inserted into the microscope, the 
mice imaging window is of much smaller size (55mm x 75mm). The length of 
the mice imaging window is the same as a histological glass slides, which 
means it fits to the object stage of microscope just like a glass slides. This 
feature increases the adaptability of the window to different modal of 





Figure 3-4. Different views of mice imaging window design. This design is revised 
based on the second generation rat imaging window design, but it is in a much smaller 
size. It could be stabilized to the microscope’s sample plate like histology slides. This 
feature makes it able to adapt to different microscope models. 
 
 
Figure 3-5. The fabrication of mouse imaging window. (a) There are three main 
components in this design; only the inner ring is made of medical grade titanium, the 
other two parts are made of aluminum alloy. (b) The assembled window is showed. 
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The mouse window is designed at the size of a glass slide, so it easily fits to different 
microscope models. 
 
3.2.2 Statistics of laser speckle 
The computation of the spatial contrast is achieved by sliding a window with 
pixel size of 5×5 or 7×7 over the whole raw image and estimate the contrast, 
the contrast will be assign to the middle pixel of the window. This can be 
realized in MATLAB by: 
winsz = 5; %window size 
Imp = padarray(Im,[winsz winsz],'replicate');% pad the border of the image by replicating the 
border element, Im = raw image 
conIm = nlfilter(Imp,[winsz winsz],@contrast); % sliding the window through the image by 
performing the 'contrast' function 
 
% ‘contrast’ function 




The computation of temporal contrast uses temporal standard deviation and 
temporal intensity mean, which is achieved from the statistics along n (usually 
n = 20) frames of images in temporal dimension. This can be realized in 
MATLAB by: 
% read image of size rownum * colnum to a combo 
for comboindex = 1:n; 
    combo(1:rownum,1:colnum,comboindex) = imread(filename); 
end 
  
% calculate the temporal contrast of each pixel 
for rowindex = 1:rownum; 
    for colindex = 1:colnum; 
        tempstd = std(combo(rowindex,colindex,:)); 
        tempmean = mean(combo(rowindex,colindex,:)); 
        tempconIm(rowindex,colindex) = tempstd./tempmean; 




3.2.3 Experiment setup and image acquisition 
The experiment set-up is presented in Figure 3-6(a). The wide-field 
illumination provided by a mercury lamp passed through a long pass filter set 
(ET470/24x, 510dcxr, HQ525lp, Chroma Technology), the specifications of 
each filter is listed in Table 3-1. The LSCI employed a diode laser 
(CrystaLaser, USA, λ=638nm, 25mW) to coherently illuminate the imaging 
site with an incident angle of about 30 deg. Images were acquired by the CCD 
camera (DP72, Olympus) after light passing through the objective lens (LD 
Plan-Neofluar, 20x, NA=0.4, Carl Zeiss). For each imaging site, five 
wide-field fluorescence images were taken followed by 200 frames of raw 
speckle images with size of 1024×1360 pixels and capture frequency of 15Hz. 
The exposure time was set to 75ms for fluorescence images and 20ms for 
speckle images.  
 
Table 3-1. The specifications of long pass filter set. 
Filter type  Quote number Specifications 
Emission  ET470/24x CWL:470nm, FWHM:24nm 
Dichroic  510dcxr Cut on/off: 510nm 
Excitation  HQ525lp Cut on/off: 525nm 
 
2D blood flow map was obtained by calculating the speckle contrast 
temporally, which is to estimate the speckle contrast from 20 consecutive 
frames of raw images in the temporal dimension. To increase the signal-to 
noise ratio, we used the average of 10 speckle contrast images to analyze the 
blood flow. The resulting wide-field fluorescence image in showed in Figure 
3-6(b), the result blood flow map is showed in Figure 3-6(c). The blue color 





Figure 3-6. (a) Schematic illustration of the optical set-up. For the wide-field 
fluorescence microscope, the light generated by mercury lamp passes through a long 
pass filter set (ET470/24x, 510dcxr, HQ525lp, Chroma Technology). The LSCI 
recruits a diode laser (λ=638nm, 25mW output) as light source with an incident angle 
of about 30deg. Resulting images were collected by a CCD camera. (b) Wide-field 
fluorescence image. (c) Blood flow contrast color map of the same imaging site. Scale 
bar: 100um. 
 
3.2.4 Liver fibrosis model establishment by Bile Duct Ligation 
(BDL)  
In this experiment, we use Bile Duct Ligation (BDL) surgery to create liver 
fibrosis model. The procedure of the BDL surgery is as follows: 
 
Before the surgery, surgical instruments are autoclaved at 121°C for 30 
minutes. Autoclaved items are dated, labeled and must be used within a week. 
Surgical space is disinfected with 70% ethanol. The rats are transported to the 
preparation room and sedated, under general anesthesia with ketamine 
(75mg/kg) and xylazine (10mg/kg) (148). Animals are then shaved on the 
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abdomen and fur is removed with a vacuum evacuator. Operation site is 
scrubbed with 1% iodine followed by 70% ethanol, repeated three times. The 
rat will be injected with 5ml 0.9% NaCl S.C perioperatively. The abdomen is 
then draped. The surgical team will do a five minute wash of hands and 
forearm to remove the microbes from the skin, using chlorhexidine 
preparations. Hands are rinsed with running water from hand to elbows and 
dried with sterile towels. The surgeon then wears gowns and gloves with the 
help of an assistant, ensuring sterile technique. 
 
Common BDL of rat is performed according to the protocol of Maria-Angeles 
Aller et.al (149). Briefly, a midline laparotomy is performed, exposing the 
liver. The common bile duct is doubly ligated in two areas near the hilum with 
6-0 silk suture and then transected between the two ligation points (Figure 3-7). 
Abdominal contents are gently rearranged, and the wound is closed with 
double layered tissue closure using 3-0 vicryl sutures. Tetracycline HCL is 
applied on the closure wound and plastered with a water proofing protection. 
 
After the surgery, animal will be monitored every 4 hours the first day, and 
every 24 hours till the day on which the rat is ready for imaging. The appetite, 
condition of the surgical wound, state of arousal, indices of pain or discomfort 




Figure 3-7. The illustration of the transaction site of on the common bile duct. Picture 
is adapted from ref (150). The bile duct is transected between two ligatures. RLL: right 
lateral lobe. ML: middle lobe. LLL: left lateral lobe. CL: caudate lobe. CP: caudate 
process. 
 
3.2.5 Animal preparation for in vivo microcirculation study 
To prepare the animal for the in vivo imaging experiment, rat is anesthetized 
using ketamine (75mg/kg) and xylazine (10mg/kg) (148). A midline incision 
of abdomen skin and muscle is created after shaving. The inner ring of the 
hepatic imaging window is sutured inside the abdominal wall through the 
holes on the ring. In order to minimize motional artifacts associated with 
respiration, tissue adhesive (vetbond 3M, USA) is applied to the edge of the 
inner lid to adhere the left lobe of liver to the ring. A cover glass is then 
adhered to the lid to serve as an observation window. The following procedure 
of applying imaging window is using the first generation rat imaging window. 
The rat with the window installed is kept in the supine position, then the 
window is fitted into the U-shape ring holder, which is then screwed tight to 
another round ring holder that fits into the steel plate. There is a small screw 
on the flank of the plate to lock the round steel plane. The plate is then 
attached to the stage for live imaging purpose. A hot pack is put on top of the 
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rat for warming purpose. All experiment procedures described in this chapter 
are carried out in compliance with the National Advisory committee For 
Laboratory Animal Research (NACLAR) Guidelines. The protocol is 
approved by Institutional Animal Care and Use Committee. inserted to the 
microscope sample stage. In this way, the rat could be firmly  
 
For the experiment of looking for microcirculation imaging features, a total of 
15 rats at the age of 9-12 week old are ligated and proceeded to in vivo 
imaging at intervals of 1, 3, and 5 weeks (n=5 per week) after ligation. 
Another five rats are sham operated and sent to in vivo imaging as a control 
group. To prepare animal for in vivo study, the hepatic imaging window was 
used to expose the liver for imaging.  
 
3.2.6 Image segmentation and features extraction 
Image processing is performed to quantify the resulting images using 
MATLAB (Mathworks, Massachusetts). The wide-field images are first 
filtered by the Frangi filter (151, 152) to enhance the blood vessel conduit 
from a noisy background. Different scales of the Gaussian kernel with σfrom 1 
to 8 are used in the Frangi filter and the intensity of each pixel in the filtered 
images is assigned with the maximum output value of the Frangi filter among 
all the scales assessed. The filtered images are then thresholded. Delaunay 
triangles are computed from the thresholded image boundary points. The 
medial axis transforms (MATs) are obtained from the Delaunay triangles 
(153). The MAT consists of the vessel centerline and radius. The flowchart of 
imaging processing procedure is illustrated in the Figure 3-8. Four parameters 
are identified through imaging processing. They are (1) number of junctions 
inside each image; (2) the averaged vessel breadth, which is the averaged 
diameter of the vessels within each image; (3) the vessel area, which is defined 
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as the integral of the diameter of vessel over the vessel length; (4) the average 
perfusion speed. In order to obtain the averaged perfusion speed, we identify 
the vessel region on the LSCI blood perfusion map. The contrast value of 
every pixel within the vessel region is averaged and transferred to the speed 
according to the relationship between contrast value and the speed. 
 
Figure 3-8. The flowchart of imaging processing procedure. Raw wide-field 
fluorescence image is firstly Frangi filtered and thresholded to obtain the binary image. 
Delaunay triangle was computed and the MAT was acquired to get the vessel centerline 
and radius. Using the resulting centerlines and radii of all vessels, the vessel structure 
could be reconstructed, so that the feature of number of junction, average vessel 
breadth and vessel area can be extracted. Combing the reconstructed structure and the 
laser speckle contrast flow map enables us to identify the vessel region and obtain the 
averaged flow speed. 
 
3.2.7 Quantification and statistics analysis 
Statistical analysis is carried out using SPSS 20 (IBM Corporation). The rats 
are grouped into different stages according to the tissue histological review. 
Since multiple images are taken from a single rat, each image is treated as a 
sample. Because the normality assumptions are not always satisfied for every 
group, the equivalent non-parametric Mann Whitney U/Wilcoxon Ranked 
Sum test is used to test the differences of each feature between two 
consecutive groups. p<0.05 implies a statistically significant difference. Data 
52 
 
is presented using mean±s.e., The data is normalized towards the mean of the 
normal group. ROC Curves are also plotted to evaluate and compare the 
performance of each parameter in classifying the disease progression.  
 
3.2.8 Liver sample extraction, processing and staining 
After in vivo imaging, before the animal is euthanized, one dose of 0.5ml 
heparin is given to the rats injected through tail vein, to suppress the blood 
platelet agglutination; then cardiac perfusion with 10% paraformaldehyde is 
performed to flush out the blood cells and fix the liver tissue before harvesting. 
Liver specimens from left lateral lobe are preserved in buffered fixative for 
further slicing preparation. 
 
After fixation, the tissue is dehydrated by first using graded ethanol solutions, 
followed by graded xylene solutions and finally liquid paraffin. The graded 
solutions would expose the sample to changes in hydrophobicity gradually, 
thus minimizing the damage to cells. After a short time in the liquid paraffin, 
the tissue is placed into a mold with more paraffin. In this way, the infiltrated 
tissue is embedded into a paraffin block. The embedded samples are then cut 
into 15µm thick sections. After the several slices of the paraffin-embedded 
tissue have been sectioned, the slices are removed from the blade and floated 
atop a warm water bath to smooth out the sample. The slices are teased apart 
and floated onto a glace slide. Place the slides with paraffin section on the 
warm block in a 65oC oven for 20 minutes in order to melt the wax and bond 
the tissue to the glass. To prepare the slides ready for staining, deparaffinize 
the slides with 2-3 changes of xylene and hydrate in increasing graded ethanol 
solutions, then rinse with distilled water. Every two consecutive tissue samples 




3.2.9 Histopathological scoring of tissue sample 
The stained tissue slides are imaged with bright-field microscopy (Aperio 
Digital Pathology Environment). Animal tissue score is performed by 
experienced histopathologist based on modified Ruwart score according to 
Ruwart et al (154) and Boigk et al (155). Because there is extensive bile duct 
proliferation noted. The modified Ishak (156) score is also considered and 
served as a guide to commensurate animal pathological score with the clinical 





3.3 Results and discussions  
3.3.1 Intravital imaging window for live liver imaging 
All three designs of the imaging window can meet the requirement of stability. 
The second generation rat imaging window is much easier to handle than the 
first generation, the mice imaging window based on the second generation rat 
imaging window is also handy to use. During the experiment, we compared 
the inner ring made of titanium alloy and aluminum alloy, and found that the 
imaging window fabricated using titanium alloy is more durable, because 
repeated autoclaving of the imaging window will deform the fine features, 
such as the brim of the slide slot, if the window is made of aluminum alloy. 
Besides, the titanium alloy is less tending to induce inflammation reaction of 
the abdominal wall than aluminum alloy. Therefore, that the titanium alloy is 
the most desirable material for such implantable device. Considering the price 
of fabrication, we finally decided to fabricate only the implantable part with 
titanium, the other parts are still made of aluminum alloy.  
 
Figure 3-9 illustrates the usage of the imaging window on rats. Four steps are 
involved in achieving this: first, suturing the inner ring to the abdominal skin 
of the rat (Figure 3-9(a)); second, insert the inner ring to the u-shape holder 
and lock the u-shape holder by screwing it to the ring holder (Figure 3-9(b)); 
third, insert the ring holder to the plate and lock it using the small screw on the 





Figure 3-9. The illustration of using the imaging window on rat. (a) Suturing the inner 
ring to the abdominal skin of the rat. (b) Connecting both the U-shape holder and the 
ring holder to the inner ring. (c) Locking the ring holder to the plate. (d) Placing the 
plate to the microscope stage. 
 
Some points require full attention during the experiment: first, when using the 
tissue adhesive, we must be cautious not to apply too much and never make 
the adhesive to drop onto the liver surface. The adhesive is volatile and easy to 
create haze if applied too much. Under the two-photon microscope, the 
adhesive could generate second harmonic generation (SHG) signal as the 
collagen inside the liver capsule does, therefore dropping of tissue adhesive on 
the liver surface could confuse the imaging result; second, the artificial 
movement due to animal breathing and heartbeat is a big headache during the 
live imaging of animal liver. In order to reduce this effect, the depth of the 
anesthesia is of most importance. Controlling the anesthesia is nothing more 
than experience of anesthetics dosing according to the animal weight and 
health status.  
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3.3.2 Spatial and temporal laser speckle contrast 
Spatial contrast and temporal contrast are two methods to resolve laser speckle. 
Spatial speckle contrast is estimated from the mean and standard deviation of 
the speckle intensity, which are generally determined from a square region of 
௣ܰ௜௫௘௟௦ (i.e. ௣ܰ௜௫௘௟௦
ଵ/ଶ ൈ ௣ܰ௜௫௘௟௦ଵ/ଶ ). A larger value of ௣ܰ௜௫௘௟௦ will yield a more 
accurate estimate of speckle contrast, but at the expense of spatial resolution. 
It is suggested that the window size of 5×5 or 7×7 pixels are reasonable 
trade-off between spatial resolution and uncertainty in the estimated speckle 
contrast. However, it all depends on camera resolution, speckle size, and 
desired contrast resolution. To study the effect of window size on contrast 
value (K), we chose one images as Figure 3-10(b), the corresponding 
wide-field fluorescence image is showed in Figure 3-10(a), spatial contrast 
was calculated when window size equals to 3×3, 5×5, 7×7, and 9×9. The 
resulting flow maps are showed in Figure 3-10(c) - (f). It’s obvious that the 
spatial resolution has decreased with the enlargement of the window size. In 
Figure 3-10(f) the grain appearance has been very obvious because of the loss 
of the spatial information. We may take it for granted that the smaller the 
window sizes the better. However, the size of the window size has to 
compromise with the computing time. When the window size is small, longer 
time is required to calculate the resulting flow map. Moreover, the smaller 
window size means smaller sample size in calculating the contrast, the 
accuracy is also undermined. Therefore, the window size of 5×5 and 7×7 is 




Figure 3-10. (a) The wide field fluorescence image of liver surface. (b) The 
corresponding laser speckle raw images. (c) The resulting flow map using spatial 
contrast with window size equals to 3×3. (d) The resulting flow map using spatial 
contrast with window size equals to 5×5. (e) The resulting flow map using spatial 
contrast with window size equals to 7×7. (d) The resulting flow map using spatial 
contrast with window size equals to 9×9. 
 
To gain a more quantitative understanding of the relationship between the 
quality of contrast image and the window size, and to understand the reason of 
choosing 5×5 or 7×7 window size, we did the following test: three locations in 
the image were chosen manually, where A is a large portal vein, B is a 
sinusoidal and C is parenchyma. a 11×11 observation window were placed 
over these locations as showed on Figure 3-11 (a), the corresponding contrast 
values are obtained and plotted in Figure 3-11(b). An interesting finding is the 
contrast value becomes larger as window size enlarges. It is likely that more 
pixel values corresponding to the slower and nonmoving scatters are included 
in the computation of contrast value. Therefore, the contrast value tends to 
increase as window size enlarges. To explain the choosing of window size of 
5×5 and 7×7, 1-SD error was used as the threshold of selection criteria, when 
a K value exceeds 1-SD, it will be rejected. From the Figure 3-11(c), It is 
noticed that only when window size equals to 5×5 and 7×7, the contrast values 
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at three locations lie within the 1-SD error. It is expected that images are noisy 
when window size equals to 3×3 with most pixels have lower contrast value, 
while when window size equals to 9×9 most pixels have higher contrast value. 
Refer back to Figure 3-10(c) and (f), in both cases, smaller vessels disappear 
from the image. 
 
 
Figure 3-11. (a) To understand why window size 5×5 and 7×7 are widely used to 
calculate the spatial contrast, three points are chosen from the image, a 11×11 
observation window on each point, the mask were applied to the resulting flow map 
calculated using different window sizes, the resulting is plotted on (b). (c) The 1-SD 
ranges and the exact center contrast value (connected by line) are shown. Contrast 
values are beyond the range of 1-SD when the window size is 3×3 and 9×9.  
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Temporal speckle contrast images the time-integrated speckle and subsamples 
the temporal variation at 10 Hz or faster, thus it images all pixels in parallel 
but does not resolve the high-frequency temporal variation. The temporal 
speckle contrast K୲	is obtained with the temporal standard deviation σ୲ of the 
speckle intensity divided by the mean intensity. Both parameters are achieved 
from the statistics along n frames in the temporal dimension. By using 
temporal sampling to estimate the speckle contrast, rather than spatial 
sampling, the result can maintain a higher spatial resolution but at the expense 
of temporal resolution. The number of frame that is used to calculate the 
contrast remains to explore. We use the same data set as showed in Figure 
3-10, and in Figure 3-12 the temporal contrast K୲ to the number of frames n = 
2 to 30 are plotted. It turns out that the contrast values become more stable 
when n increase after n = 16 (from frames 16-30) than after n = 10 (from 
frames 10-30). Practically the time of processing the data prolongs when a 
larger n is used, to gain a good balance between the time cost and the accuracy 
of the processed data, n = 20 is chosen in all the later data processing. To 
balance the advantage and disadvantage of spatial contrast and temporal 
contrast, temporal contrast was recruited in the later analysis since in the 
application of liver microcirculation in chronic fibrosis disease, the change 





Figure 3-12. The contrast value calculated using temporal derived contrast over n 
frames. K(A) ~ 0.015225 (within 10% of each other after n = 10), K(A) ~0.015593 
(within 8% of each other after n = 16); K(B) ~0.041807 (within 5% of each other after 
n = 10), K(B) ~ 0.042177(within 4% of each other after n = 16); K(C) ~0.056300 
(within 5% of each other after n = 10), K(C) ~ 0.055701(within 2% of each other after 
n = 16); therefore, the contrast becomes more stable if use more than 16 frames to 
calculate.  
 
3.3.3 The Histopathological findings from the tissue section of BDL 
model 
The resulting effect of the BDL surgery is to artificially stop the bile flow 
secreted from the liver from entering into the intestine. The chronic 
obstruction of bile acid causes massive activation of myofibroblasts and 
ultimately results in fibrosis. BDL model is a mature animal model that 
simulates the progression of Primary Biliary Fibrosis/Cirrhosis. The 
progression of this model is also very similar to clinical disease Billary Atresia, 
which is a serious digestive disease affecting infants.  
 
The time-related changes in liver after BDL are summarized in Figure 3-13. 
the acute injury to hepatocytes takes place in days 2-3. The cholangiocellular 
proliferation peaks at days 4-5. Acute injury was followed by continuous 
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tissue repair, showing as lymphocyte and Kupffer cell infiltration and the 
accumulation of collagen (144).  
 
Figure 3-13. The overview of dynamic changes following bile duct ligation in mice. 
BD, bile duct; HC, hepatocyte; PMN, polymorphonuclear leucocyte (figure adapted 
from ref (144)) 
 
The most obvious feature from the HE staining is the substantial distribution 
of proliferated biliary epithelial cells (BECs) as shown on Figure 3-14(d) 
(black triangles), arranging in circles. This is because BDL introduces 
biomechanical stress to BECs and triggers the compensatory proliferation of 
BECs. Bile duct elongates inside the liver in a twist and winding style, and a 
single section of the tissue would yield multiple lumens in one plane. The 
proliferated BECs stem from the portal region and sprawl towards the central 
region. The portal tracts and sinusoids were gradually squeezed by the 
proliferated BECs, plus most necrotic hepatocytes are replaced by BECs, 
causing the difficulties of distinguishing portal tracks from central region and 





The MT staining shows extensively distributed collagen in the tissue collected 
5 weeks after the BDL Figure 3-14(c) (collagen is stained in blue). Chronic 
obstruction of bile duct causes massive activation of myofibroblasts in the 
periductal region which is the basic feature of biliary fibrosis. With time going 
on and the accumulation of fibrosis becomes more and more substantial. When 
inspecting all the slides, we find the trend of collagen accumulation is from 
portal region to central region. Bridging collagen is obvious in the late stage of 
the BDL.  
 
Figure 3-14. Histopathological comparison of the normal tissue (a, b) and tissue 
collected 5 weeks after BDL (c, d). (a) and (c) are MT stained, the blue color yields the 
distribution of the collagen. (b) and (d) are H&E stained. BECs are extensively 
distributed on week 5 BDL tissue (black triangles); the vessel morphology has changed 




3.3.4 Live image acquisition with the laser speckle and wide-field 
microscope 
In the following study, we will denote progression status of fibrosis using 
fibrosis score. Fibrosis was scored from 0 to 4 with score 0 denoting no 
fibrosis and score 4 denoting the most advanced fibrosis or cirrhosis. The 
representative wide-field fluorescence images and laser speckle contrast flow 
maps of liver at different fibrosis stages are displayed in Figure 3-15. 
Although in theory, most endogenous fluorophores could contribute 
autofluorescence, the signal in Figure 3-15(a) should be mostly ascribed to the 
flavins inside the hepatocytes; because flavins have the excitation peak at 
around 470nm and emission peak at 520nm, which is in conformity with the 
filter set used in our setup. Other fluorophores, such as NAD(P)H and vitamin 
A, are not effectively excited. This might cause the hepatic stellate cells to 
become invisible under the current setup. The vasculature showed on laser 
speckle contrast flow maps coincides with auto-fluorescence images. The 
complementation of the two modalities enabled us to comprehensively analyze 
the hepatic perfusion in terms of both morphological and flow speed features. 
 
In Figure 3-15(a), all five imaging sites contain many pericentral sinusoids 
(around 15 um in normal state) and one to two central venules which multiple 
sinusoids are confluent with. If comparing the vasculature across the different 
stages of fibrosis, the most remarkable changes are dilated sinusoids radius 
and decreased sinusoids area. This finding is in agreement with previous 
research (12, 159). For normal livers, the sinusoids are radially spreading with 
the centre focused on the hepatic central venule. In fact, the liver blood flows 
through the sinusoids, where the nutrition supplying and the removal of 
metabolic products take place, then collects in central venula and later drains 
out of liver through bigger hepatic central vein. At earlier stages (stage 1 - 
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stage 2) of fibrosis, sinusoids seemed atrophic with sinusoids looked shrunken 
but the general pattern is mostly preserved. Multiple reasons could lead to this 
change, including the inflammation induced by detained bile acid that 
promotes the neutrophil accumulation, extravasation, and activation (160); the 
proliferation of biliary epithelia cells (BEC) (144) that take the space of 
sinusoids (black triangles in Figure 3-15(c)); and the collapse of the 
hepatocytes that destroy the structure of the sinusoids. The exact mechanism is 
beyond the scope of this study. Whereas from stage 2 to stage 3, the pattern of 
sinusoids changed more drastically, most previously atrophic sinusoids start to 
disappear, leaving large sinusoidal-free space, while the remaining 
micro-vessels, supposedly the central venula, have their diameters 
significantly distended. This change is similar to the microvascular change 
reported on fibrosis models induced by carbon tetrachloride (CCl4) (12) , even 
though the etiologies are totally different.  
 
The combining of laser speckle contrast technique with wide-field 
fluorescence microscope enables us the imaging capture and analysis of liver 
microvasculature (morphological) and dynamic information. Although the 
laser speckle contrast technique is a powerful technique in mapping the blood 
perfusion, the measurement of the absolute flow speed is impossible. The 
reason is that the physics of the scattering process is so complex and right now 
the relationship between the absolute flow speed and fluctuation of the speckle 
pattern is still not clear. Works will no doubt continue to find solutions to this 
problem. Therefore strictly speaking, this technique is a semi-quantitative 
technique. Besides, laser speckle contrast technique is purely 2D imaging of 




Figure 3-15. Wide-field fluorescence images and laser speckle contrast flow maps at 
different fibrosis stages. (a) auto-fluorescence images; (b) laser speckle contrast flow 
maps, the blue color indicates faster speed, the red color indicates slow speed; (c) tissue 
sections stained with Hematoxylin/Eosin; (d) tissue sections stained with Masson 




3.3.5 Quantification of the four parameters 
The quantified results of four microcirculation parameters, namely number of 
junctions, average vessel breadth, vessel area and perfusion speed at different 
time point are shown in Figure 3-16. Generally, the number of junctions has 
decreased (Figure 3-16 (a)) with the progression of liver fibrosis, suggesting 
that the vasculature has simplified and distorted. This might be due to the 
detained bile inside tissue creating a toxic environment for hepatocytes, 
resulting in focal necrosis. At the same time the occlusion of bile acid induced 
the massive proliferation of bile duct epithelial cells, which took the place of 
the necrotic hepatocytes. The extinction of hepatocytes leads to the collapse of 
the tissue and the loss of sinusoids. Figure 3-16 (b) shows the increasing 
averaged sinusoid breadth. The parenchymal pressure might have increased 
due to the obstruction of the sinusoids, increasing the resistance for blood 
inflow and inducing the dilation of afferent vessel. The changing in the early 
stage is not statistically significant, only the increase from stage 2 to stage 3 is 
significant with p<0.001. In Figure 3-16 (c) we quantified the overall 
perfusion area within each image. The result shows that the overall perfusion 
area is vastly decreased with the progression of the fibrosis. This should be 
due to the loss of the sinusoids, because smaller sinusoids coalesce into very 
few larger vessel-like structures. Combining Figure 3-16 (b) with Figure 3-16 
(c), the effect of sinusoids loss has surpassed the effect of dilation of the 
afferent vessel, so that the whole tissue is under-perfused due to the loss of 
micro-vascular capacity. Figure 3-16(d) reveals that the blood perfusion speed 
has dramatically increased in the remnant vessels. We speculate that the 
decreased overall vessel lumen together with the increased portal pressure 
(161) has pushed the blood volume into the remnant vessel with higher speed. 
This finding is consistent with the description of the ‘fast sinusoids’ in 





Figure 3-16. Quantification of four features extracted from the obtained 
auto-fluorescence images and laser speckle contrast images. With the progression of 
the liver fibrosis, (a) the number of junctions steadily decreases; (b) the average vessel 
breadth changes only from stage 2 to stage 3; (c) the average vessel area decreases 
steadily; (d) the perfusion flow rate map increases drastically. All the results presented 
are normalized to the mean of the stage 0 (normal). *** p<0.001, **p<0.01, *p<0.05 
 
3.3.6 Vessel cross-section speed comparison 
Cross-sectional intensity profiles of the speckle blood flow map from normal 
rat (Figure 3-17(a) and (b)) and end stage fibrotic (Figure 3-17(c) and (d)) rat 
are also compared. We manually chose three different locations in the main 
vessel from both normal and fibrotic images, and translate the intensity into 
relative speed based to the relationship between laser speckle contrast and 
speed. The calculated resulting speed of every pixel is plotted in the right 
panel. The flow speed curve of normal liver (A-A, B-B, C-C) along the cross 
section is more parabolic fitted, in contrast, the flow speed curve of the 
fibrotic liver (D-D, E-E, F-F) are prone to fluctuate more seriously. We 
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speculate the reason of this to be the imbalance between the increased portal 
pressure and the decreased resistance, which has deprive the hepatic 
microcirculation system of the normal fluid behavior. 
 
Figure 3-17. The cross-sectional speed of main vessel of normal liver (a and b) and end 
stage fibrotic liver (c and d). The sections are manually chosen as indicated as white 
line. The pixel intensity of the pixels on the line are translated into speed and plotted on 
the diagram on the right panel. Scale bar: 100µm. 
 
3.3.7 The onset of the microcirculation lesion is the early to middle 
fibrosis 
While the vessel average breadth is not changing constantly through the 
fibrosis progression, we exclude it in further ROC analysis in assessing 
features’ ability of detecting every stage of fibrosis. The ROC analysis result is 
showed in Figure 3-18. The larger area under the curve (AUC) indicates the 
better sensitivity and specificity in differentiating certain stages. An AUC of 
0.5 represents a random classification. All three features perform well in 
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detecting fibrosis from normal (stage 0 vs. stage 1, 2, 3, 4) and in detecting 
significant fibrosis from insignificant fibrosis (stage 0, 1, 2 vs. stage 3, 4) with 
AUC larger than 0.95. However, all three features have weak ability in 
detecting end stage fibrosis (stage 0, 1, 2, 3 vs. stage 4). This result suggested 
that, the drastic change of microcirculation takes place mainly in the early to 
middle stages of fibrosis in this model, preceding the accumulation of vast 
amount of the collagen (stage 4). The alteration of microcirculation results in 
progressive restriction of blood-liver exchange as a secondary injury to 
obstructive cholestasis contributing to liver fibrosis progression. 
 
Figure 3-18. The receiver operating characteristics (ROC) curve analysis of the three 
selected features to demonstrate the performance of each feature in differentiating 
fibrosis stages. All three features perform worse in detecting the end stage fibrosis, 





3.4 Summary and conclusions 
In this chapter, we start with the design and validation of intra-vital imaging 
window for in vivo liver imaging. The establishment of the dual modality 
microscopy combining wide-field microscope and LSCI was then described in 
detail. Its ability of quantitatively detecting hepatic microcirculation lesion 
without labeling has been demonstrated on a rat obstructive cholestasis 
induced liver fibrosis model. By extracting four microcirculation related 
features from the resulting images, including increased radius of sinusoids, 
decreased perfusion area, changed pattern of vasculature and increased blood 
perfusion speed were revealed, significant microcirculation lesion has been 
observed in the early to middle stage of fibrosis. Because hepatic 
microcirculation lesion is a good indicator of early stage liver disease, 
detection of hepatic microcirculation lesion would shed light on the 
progression of the disease. We also envision further development of this 
bimodal imaging method to monitor the liver disease progression for drug 
screening on an animal model.  
 
In this chapter, we have demonstrated the correlation between the 
microcirculation features and the staging of fibrosis. During the experiment, 
we use the histological score to denote the staging of fibrosis. Our experiment 
results show the microcirculation features already have a significant change 
from normal to stage 1. However, according to our prior knowledge, the 
collagen is accumulating drastically from stage 3 to stage 4. We therefore infer 
that the change of microcirculation features precede the change of collagen 
and maybe even other features. To prove this inference, we need to further 
explore other surface features that can be quantified and denote the disease 
progression. Therefore, in the next chapter, we will explore quantitative 
structural surface features to denote the disease progression.   
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Chapter 4 Study of Liver Surface Structural Features 
Related to Liver Disease status 
4.1 Introduction  
In this chapter, we aim to look for quantitative liver surface structural features 
that related to the disease status. The modality used here is nonlinear intravital 
microscopy. Intravital imaging using nonlinear microscope has been extremely 
successful in skin microvascular (162), neurophysiology (104, 163) and 
cerebroma research (164, 165), owing to ingenious design and application of 
dorsal skin / brain window. However, intravital liver investigation using 
imaging window is still limited, because of the opacity of the liver tissue and 
the existence of profuse blood in liver. With the development of nonlinear two 
photon intravital microscope with deep-penetration ability (103) in recent 
decades, there are some study of liver using two photon microscope (112, 147). 
However, rare studies focus on the structural features of the liver surface. 
Structural features on the liver surface reflects functioning changes of the liver 
in pathological status (77, 166). The ability to visualize these features with 
micrometer-scale resolution is therefore significantly important for both 
physiological studies and disease diagnosis of the liver. Although several 
methodologies have been proposed to probe liver (167, 168), the major 
limitation remains the absence of label-free and high-resolution methods that 
provide a fast quantitative visualization of various surface features in the 
native microenvironment of the living tissue. Therefore, our goal is to 
establish the methodology to visualize the structural feature on liver surface 




In this part of study we used nonlinear two photon microscopy to obtain the 
detailed structural and functional information from liver surface at cellular and 
sub-cellular level. Two photon microscopy relies on the nonlinear excitation of 
fluorescence molecules or the induction of second harmonic generation. To 
brief its principle: two near infrared wavelength photons interact 
simultaneously with a molecule or structure in the sample, resulting in the 
emission of the one photon in visible range. Since the signal generation in two 
photon microscope occurs in a confined volume, it has the three dimensional 
sub-cellular spatial resolution. Particularly, Longer wavelength excitation 
allows deeper penetration compared to confocal microscope (169). Besides, 
two photon signals and second harmonic signals can be obtained by using the 
same excitation wavelength but separate detectors to visualize several intrinsic 
sources of contrast (170), which means this method posses multimodal 
capability. Previous studies have shown the use of two-photon excited 
fluorescence (TPEF) for visualizing the distribution of intrinsic components 
such as reduced pyridine nucleotide (NAD(P)H), oxidized flavoproteins (Fp), 
elastin, and so on (171-173). Second-harmonic generation (SHG) has been 
proven to be a sensitive probe of the structural organization of collagen in 
tissues (174-176), therefore it is an effective approach for imaging collagen 
fibers in the liver.  
 
Using nonlinear two photon microscope, we have developed a label-free, 
three-dimensional quantitative and sensitive method to visualize various 
structural features of liver surface in living rat. We created the liver disease 
model by BDL surgery, because it is a well-established experimental animal 
model of extrahepatic cholestasis. In the experiment, we compared the 
obtained TPEF and SHG image from the normal liver and the liver at 5 weeks 
after BDL surgery. Using imaging processing techniques, we quantified 
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micro-structural features of liver surface with respect to the sinuosity of 
collagen fiber, and the ratio between elastin and collagen and the redox index. 
The results confirmed the ability of the methodology and this study highlights 
the potential of this technique as a useful tool for pathophysiological status 
studies and diagnosis of liver disease with further development. 
 
The developed methodology also provides a good approach to explore 
imaging markers that related to hepatic inflammation. Hepatic inflammation is 
an important feature for the early phase of chronic liver disease. The detection 
of tissue inflammation mostly counts on blood test or immunohistochemical 
method, and little research is about the imaging marker of liver surface that 
related to hepatic inflammation because of the difficulty in specifically 
labeling and visualization of Kupffer cells and neutrophils. At the end of this 
chapter, we discussed the future study of the using the developed methodology 




4.2 Materials and methods 
4.2.1 Animal preparation for in vivo imaging 
In this experiment, we created the liver disease model by conduct BDL surgery. 
The procedure of BDL surgery has been described in the last chapter. The rats 
after BDL surgery are used at week 5 as the disease group. Normal rats are 
used directly for imaging as control group. Each group has 5 rats to maintain 
statistical meaning in the later quantification. The procedure of preparing 
animal for intravital microscope investigation has also been described in detail 
in the last chapter. 
 
4.2.2 Nonlinear microscope and image acquisition 
The nonlinear optical system is achieved as described previously (77). The 
setup of the nonlinear two photon microscope we used for experiment is 
showed in the Figure 4-1. The microscope setup is based on a commercial 
laser scanning microscopic imaging system (Zeiss LSM 510 META, Jena, 
Germany) coupled to a femtosecond Ti: Sapphire laser (Mai-Tai broadband, 
Spectra-Physics). The wavelength of the output laser is set at 810 nm for the in 
vivo experiment. The laser passes through a pulse compressor (Femtocontrol, 
APE GmbH, Germany) and an acousto-optic modulator (AOM) for group 
velocity dispersion compensation and power attenuation respectively. The 
polarization direction of the laser beam is the horizontal polarization. Oil 
immersion objectives (40×, NA = 1.3 and 60×, NA = 1.4, Carl Zeiss) are 
employed for focusing the excitation beam into tissue samples (average power 
at the sample is around 10 mW) and are also used to detect the intrinsic TPEF 
and SHG signals. The detection of the signal is using the Photomultiplier tube 
(PMT), Hamamatsu R6357, Japan). In the experiment, three detection 
channels are used: two channels (430-490 nm and 500-560 nm) are used to 
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collect TPEF signals, whereas another channel (390-410 nm) is used to record 
SHG signal. These three channels recruit the same system parameters, 
including laser power, detector gain, amplifier gain and amplifier offset. To 
change and record the focus position, a fine focusing stage (HRZ 200 stage, 
Carl Zeiss) is used. The images are obtained at 2.56 μs per pixel. Two-photon 
images are recorded from the capsular and sub-capsular regions of liver 
surface. For each rat, the preparation and in vivo imaging is completed within 
2 hours as required by the animal experiment protocol. 
 
Figure 4-1. Schematic illustration of the optical configuration. Excitation laser is a 
tunable mode-lock laser (710nm-990nm, set as 810nm for in vivo experiment) with a 
pulse compressor (PC, not shown in diagram) and an acousto-optic modulator (AOM) 
for power control. The laser beam goes through a dichroic mirror, optical scanner and 
an objective lens. The emitted TPEF and SHG signal from the liver goes back through 
objective and goes to the reflective optical grating after descanned. 
 
4.2.3 Feature extraction and quantification 
To further quantify the images acquired from the liver surface, we perform 
quantitative analyses. All the image processing and computation mentioned 
here are carried out with MATLAB (the MathWorks Inc, Massachusetts). The 
methods we used to perform the quantification are as follows: firstly, five 225 
μm by 225 μm rectangular areas are randomly selected on every image we 
took as the data pool. Using these data, we calculate sinuosity of collagen fiber, 
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collagen percentage and the redox ratio. The definitions of the three 
parameters are defined as below: 
1. Sinuosity of collagen fiber is a measurement of curvature of the collagen 
fiber. In each rectangular area, the curvilinear length (along the fiber) is 
defined as a while the distance (straight line) between the two end points of 
the fiber is defined as b. The sinuosity of collagen is defined as a/b. 
2. Collagen percentage is determined by counting the ratio of the SHG pixels 
over the whole image pixels. By this definition, collagen increase results in 
a larger collagen percentage value. 
3. Redox ratio of the cell is an common measurement of the metabolic status 
of the cell (177). The pixel intensity of NAD(P)H on the images taken from 
spectral band 430-490 nm and the pixel intensity of Fp on the images taken 
from spectral band 500-560 nm were defined as a and b respectively. The 
Redox ratio is defined as a/b. 
 
We also define another feature named elastic fiber structure. It was analyzed 
by using the gray-level co-occurrence matrix (GLCM) module (178). This 
module examines texture features based on the spatial relationship of pixels, it 
characterizes the texture of an image by calculating how often pairs of pixel 
with specific values and in a specific spatial relationship occur in an image. 
The basic step of using this module is to create a GLCM first based on raw 
image, and then extract statistical measures from the matrix. It can be achieved 






4.3 Results and discussions  
4.3.1 Liver surface in vivo imaging using two photon microscope 
Here we demonstrate firstly the in vivo liver surface imaging using nonlinear 
two photon microscope. The rat we used here is a normal 12-week-old Wistar 
rat. The rat with the window installed is stably accommodated onto the 
microscope stage of the nonlinear two photon microscope. The setup of the 
two photon microscope has been described in last section. The resulting 
images are showed in Figure 4-2. We took the z-stack with 2 µm interval. In 
the figure, we only showed the image as deep as 14um but in fact we were 
able to obtain satisfying image result as deep as 38 µm in this experiment 
without changing the PMT voltage. Beyond 38 µm, the signal becomes weak, 
the PMT voltage has to be increased. Practically, according to my experiment 
experience, the system could achieve a penetration depth of 100 µm. Although 
this depth is still smaller than the 1000um depth claimed by the Theer et.al 
(179) in the imaging of animal brain using two photon, it is deeper than any 
other modalities in liver in vivo imaging used currently, considering the 
opacity property (liver is heavily pigmented tissue) of the liver organ. The 
profuse red blood cells inside the liver could also increase the scattering of 
both the excitation and emission photons. Besides the property of the tissue, 
the maximum penetration depth depends largely on the laser power and the 
detection efficiency. Our system uses descanned detection scheme, in which 
the fluorescence signal returns through the scanning system before reaching 
the final detector. We believe this detection scheme is less optimized than 
non-descanned detection scheme in collecting scattered fluorescence signal. 
To fully take advantage of the two-photon excitation technique to achieve 




The image resolution of the two-photon microscope is actually not better than 
that achieved by a confocal microscope because of the use of the longer 
excitation wavelengths. To estimate the lateral and axial resolution of the 
two-photon excitation microscope, we use the resolution equations for 









where rxy and rz represent lateral resolution and axial resolution separately, λ is 
the wavelength, NA is the numerical aperture of the objective. According to 
the equation the lateral resolution is 0.29 µm, the axial resolution is 1.08 µm. 
 
To generate SHG signal, the sample object must contain certain material that 
has specific molecular orientation, so that the incident light could be frequency 
doubled. Some biological materials are highly polarized. For example, 
collagen in liver tissue, especially collagen type I and type III (180) is an 
efficient sources of SHG signal because of its noncentrosymmetric structure 
(174, 175), so the resulting SHG (the detection filter is band pass 390-410 nm) 
images in the first column of Figure 4-2 results from type I and type III 
collagen. Liver surface is covered by an around 10 µm thick collagenous layer 
called the Glisson’s capsule (75), and from the figure, we see it generate 
strong SHG signal (from d = 2 µm to d = 6 µm). With depth goes deeper and 
deeper, SHG signals becomes less and less, because the collagen distribution 
within the normal liver is scarce. From previous studies of liver structure 
(77), we know that TPEF image is suitable for hepatocytes morphology 
observation, because when excited with a femtosecond pulsed laser, intrinsic 
molecules inside hepatocytes, such as NAD(P)H and Fp, emitted substantial 
fluorescence. The second column of Figure 4-2 shows the distribution of 
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TPEF signals (the detection filter is band pass 500 -560nm). The boundary of 
the hepatocytes is clear as well as the location of the nuclei which is shown as 
dark ellipsoid. The brighter red signal inside hepatocytes shows the bile 
canaliculi, which is the conduit for bile secretion. The autofluorescence of bile 
ascribable to bilirubin could also be excited by two-photon laser, and its 
emission range is 510-600nm (181).  
 
To demonstrate the ability of two photon microscopy in liver in vivo imaging, 
other than the autofluorescence imaging of the liver, we have also explored the 
in vivo imaging using nonlinear two photon microscope when introducing 
external contrast agent. Figure 4-3 showed the hepatic microcirculation of live 
rat in a normal state and five weeks after BDL surgery. The microcirculation is 
highlighted with Rhodamine B dextran injected through jugular vein. From the 
image, there is drastic difference of the microvasculature between the two. The 
image was taken using a 10× objective lens, so that the field of view has 
covered a hepatic lobule that contains few portal regions and a central region. 
Figure 4-4 shows the labeling of both microcirculation and nucleus. The 
nucleus is labeled using BrdU. As BrdU incorporated into DNA during 








Figure 4-2. The liver in vivo imaging using nonlinear two photon microscope. The 
first column is SHG signal resulted from collagen (type I and type III), the second 
column is TPEF signal resulted from the intrinsic molecules such as NAD(P)H, Fp and 
bilirubin. The third column is the overlay of both channels. The images are taken as a 
z-stack with 2 µm interval; the deepest signal actually comes from 38µm (not shown). 
The size of the field of view is 150µm x 150µm, scale bar: 50µm. 
 
 
Figure 4-3. The image of hepatic microcirculation of normal rat (a) and BDL rat after 
5 weeks (b). The external contrast agency Rhodamin B dextran was injected through 
the jugular vein of the rat to highlight the microcirculation. Scale bar 200µm. 
 
 
Figure 4-4. The in vivo labeling of microcirculation and hepatic cell nucleus in a 
normal rat. The microcirculation is assigned with green color; the nucleus is in purple 
color. The enlarged region showed in (b) indicates the proliferation of hepatocytes 
which shows double nucleus. The scale bar in (a): 50µm, the scare bar in (b): 20µm. 
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4.3.2 Structural features of liver surface 
During the imaging using two-photon microscope, we noticed the emission of 
TPEF signal from the liver is very wide (from 430 nm to 560nm) under the 
excitation of 810nm laser. We hereby separate the detection spectrum to two 
bands (430-490 nm and 500-560 nm) for better analysis of the metabolic status 
of the hepatocytes. The reason for doing so is that different molecules will 
show different emission spectrum, in this way we could separate the signal 
from different molecules. In the capsular layer (from liver surface to around 10 
um depth) TPEF falls in both 430-490 nm and 500-560 nm spectrums mainly 
results from the elastin, whereas in the subcapsular layer TPEF signals within 
430-490 nm originates mainly from NAD(P)H and the TPEF signals within 
500-560 nm signal arises mainly from Fp (170, 171). 
 
In the following figures, we show the representative multiphoton images from 
in vivo normal (Figure 4-5) and diseased rat livers (Figure 4-6) at two different 
depths (capsular and subcapsular layers). For the purpose of distinguishing the 
SHG and TPEF signals, pseudocolors of grey (SHG: 390-410 nm), green 
(TPEF: 430-490 nm), and red (TPEF: 500-560 nm) were assigned. Comparing 
Figure 4-5 and Figure 4-6, several interesting results are discovered. Firstly, 
when comparing the morphological pattern of collagen and elastin, we find 
that in the normal capsular region collagen is dense with curvy subfilament 
structures and elastin displayed a fine structure with visible fibers, whereas in 
the diseased liver, capsular region collagen is less dense and straight with loss 
of curvy subfilament structures and elastin shows a breakage of fine structure 
with merged fibers. Second, in comparison with the normal capsular region, 
the diseased capsular region has an alteration in the proportions between 
collagen and elastin, as obviously shown in the combined SHG & TPEF 
figures. Third, in the normal subcapsular region there are well-organized 
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hepatocytes and only a little collagen is presented; whereas in the diseased 
subcapsular region there are some hepatonecrotic areas because of bile duct 
proliferation and some abnormal collagen, a clear indication of fibrosis, is also 
presented. Last, in the subcapsular region, the abnormal hepatocytes display 
the color of pale yellow, whereas the normal hepatocytes exhibits a more 
green, as seen in the combined SHG&TPEF figures. Because green and red 
can give yellow, the pale yellow color indicates that the proportion of Fp 
signals (red) increases in abnormal case, while a more green appearance 
reflects that the proportion of NAD(P)H signals (green) is higher in normal 
case. In other words, the abnormal hepatocytes show a lower redox ratio, 
whereas the normal hepatocytes display a higher redox ratio.  
 
 
Figure 4-5. Representative two photon images acquired from in vivo normal rat liver. 
Four columns from left to right: SHG, TPEF detected at 430-490nm, TPEF detected at 
500-560nm and combined SHG and TPEF images. Two rows from top to bottom: 
capsular region (d = 2µm) and subcapsular region (d = 20µm). The excitation 





Figure 4-6. Representative two photon images acquired from in vivo diseased rat liver. 
Four columns from left to right: SHG, TPEF detected at 430-490nm, TPEF detected at 
500-560nm and combined SHG and TPEF images. Two rows from top to bottom: 
capsular region (d = 2µm) and subcapsular region (d = 20µm). The excitation 
wavelength is 810 nm. The size of field of view is 225µm × 225μm. Scale bar: 50µm. 
 
In specific interest in the quantitative comparison of normal and diseased liver 
as mentioned above, we use the quantification method as detailed in last 
section. Presented in Table 4-1 are the quantified results of five parameters, 
namely sinuosity of collagen fiber, elastic fiber structure, ratio between elastin 
and collagen, collagen percentage and redox ratio from in vivo normal and 
diseased rat livers. As showed in the table, all the five parameters are 
significantly different between normal and diseased rat livers. Sinuosity of 
collagen fiber is a parameter for the morphological shape of the collagen. It 
was found that the sinuosity of collagen fiber of normal rats is significantly 
higher than that of abnormal rats. Specifically, it is 1.50±0.13 for normal rats 
and 1.26±0.06 for diseased rats. This observation is in conformation with the 
notion that BDL surgery leads to higher expansion force in the liver surface, 
which cause straight collagen fibers. This could also link to the increased 
stiffness of liver tissue during the progression of liver fibrosis, which lays the 
basis for application of elastography for liver fibrosis measurement (182). 
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In our quantification using the gray-level co-occurrence matrix (GLCM), the 
correlation value at the distance of 30 pixels is defined as the elastic fiber 
structure. In this definition, a loss of fine structure leads to a bigger elastic 
fiber structure (EFS) value. Based on our quantification, the EFS for normal 
rats is 0.26±0.07, whereas for diseased rats it is 0.59±0.10, suggesting the loss 
of the fine elastic fibril structure in BDL rats. Moreover, we analyzed the ratio 
between elastin and collagen. Generally, in the capsular layer, the SHG signal 
reflects the collagen content and TPEF signal signifies the distribution of 
elastin (176, 183), we performed the analysis to cauculate the ratio of SHG 
(390-410 nm) signal and TPEF (430-560 nm) signal. The ratio for normal rats 
is 1.72±0.17, whereas for diseased rats it is 2.51±0.23, suggesting increased 
amount of elastin in BDL rats. This result also confirms the results from 
previous research that there is the regulation of elastin secretion and turnover 
after BDL (184). Finally, to analyze the subcapsular layer images, we 
quantified the collagen percentage. It is calculated as the percentage of SHG 
signal pixels to the pixels of whole image. As showed in the table, the collagen 
percentage for normal rats is 0.005±0.001 and for diseased rats it is 
0.023±0.006, reflecting collagen increase in BDL rats. The increased amount 
of collagen is in agreement with imaging study using in vitro fibrotic liver 
tissue (77).  
 
Table 4-1. Quantitative characterization of parameters derived from two photon 
imaging 
 Capsular Layer Subcapsular Layer 
SCF EFS REC CP RR 
Normal 1.50±0.13 0.26±0.07 1.72±0.17 0.005±0.001 1.24±0.12 
Diseased 1.26±0.06 0.59±0.10 2.51±0.23 0.023±0.006 0.38±0.05 
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SCF: sinuosity of collagen fiber; EFS: elastic fiber structure; REC：ratio between 
elastin and collagen; CP: collagen percentage; RR: redox ratio. Data is represented as 
mean±s.d.. 
 
4.3.3 Redox ratio indicates hepatocytes function 
The ratio of NAD(P)H over Fp fluorescence intensity, called the redox ratio, is 
a good indicator of the cellular metabolic status (171, 185, 186). In this 
analysis, we objectively selected regions where the cell boundaries can be 
identified and performed the redox ratio analysis to make sure the ratio is 
gained from the region of hepatocytes. For the diseased rats, a significant 
decrease in the RR is observed. Specifically, the redox ratio for normal rats is 
1.24±0.12, and for diseased rats it is 0.38±0.05. This observation supports the 
notion that there is a decrease in metabolic activity in this model due to 
apoptosis of hepatocytes (187).  
 
According to previous literature, the oxidation of NADPH induces the active 
neutrophils to generate superoxide. Superoxide dismutates to hydrogen 
peroxide and oxygen and thus easing the generation of neutrophile induced 
oxidant stress and cytotoxicity (186). This has related the redox status to the 
hepatic inflammation. We therefore hypothesize that the redox status is a 
surrogate of inflammation, but the demonstration of this hypothesis needs 





4.4 Summary and conclusions 
In this chapter, we focused on looking for surface structural features that could 
potentially differentiate the liver disease status. We reported a label-free, 
three-dimensional quantitative and sensitive method for visualizing various 
components of liver surface in living rat using nonlinear two photon 
microscope. The ability of this method to extract label-free quantitative 
morphological features in vivo, including the sinuosity of collagen fiber, the 
elastic fiber structure, the ratio between elastin and collagen, collagen 
percentage and the redox ratio, could provide a direct method for researchers 
to compare pathophysiologically induced changes.  
 
Currently, several commercialized two photon microscopic devices have 
demonstrated their application in clinic, including DermaInspect and MPTflex 
Multiphoton Laser Tomography from JenLab GmbH, Germany. Although to 
our knowledge, two-photon microscope integrated to the fiber endoscope has 
not yet seen commercialization, it is heavily studied as a hot research topic. 
Especially, Zhang et al. has prototyped the nonlinear endomicroscope and 
demonstrated its ability to visualize cervical remodeling during pregnancy 
(188). Thus, it is reasonable to predict that commercial development of the 
fiber based nonlinear endomicroscope may occur within the near future. For 
our developed method, I believe with the development of two photon 
endomicroscope (189-191), this method has the potential to become a useful 





Chapter 5 Study of Progression Mechanism of 
Non-Alcoholic Fatty Liver Disease  
5.1 Introduction 
NAFLD has become the main driver for the increased prevalence of chronic 
liver disease worldwide. It is also a risk factor for Hepatocellular Carcinoma 
(HCC). Yet its mechanism still requires clarification. Since NAFLD is a 
chronic liver disease that encompasses the non-alcoholic steatohepatitis (NASH), 
necroinflammation and progressive fibrosis. In the previous chapter, we have 
studied the fibrosis, in this chapter, we focus on steatosis by delineating the 
structural and biochemical features changes during the disease progression and 
in the mean time understand the mechanism of the disease.  
 
Raman micro-spectroscopy has emerged as a promising clinical detection 
tools in recent years, especially for cancer diagnosis (192, 193). The signal of 
Raman micro-spectroscope results from the inelastic scattering of photons 
induced by the intrinsic molecular bonds. Because it has the ability to acquire 
rich biomedical information, it provides a good method to probe the 
progression change of the disease. The other reason of using Raman 
micro-spectroscopy to study steatosis is its ability to probe fatty lipid. Firstly, 
fatty lipid is difficult to store in the post-processing procedure of liver biopsy, 
due to its resolvability in organic solvent. Even though Oil red staining 
method is developed as a superior fat stain, it adds the work load to common 
H&E staining and prohibits a rapid assessment of structural tissue damage. 
Secondly, for in vivo application, only Raman spectroscopy, Coherent 
anti-Stokes Raman scattering (CARS) microscopy and Third Harmonic 
Generation imaging has the ability to probe fatty lipid. Among all three 
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modalities, Raman micro-spectroscopy provides a relatively simple and 
reliable method.  
 
In this Chapter, we used the Raman micro-spectroscopy to image the fresh 
frozen tissue from the different time points of NAFLD diseased mice. The 
basic spectra change with the disease progression was analyzed. We used 
principle component analysis and biological component analysis to delineate 
the structural and biochemical feature changes. The results indicate the 





5.2 Materials and methods 
5.2.1 Animal model for NAFLD and sample preparation 
A good animal model that exactly reproduces the pathogenesis of NAFLD of 
human is not available, because the progression term may be as long as 20-30 
years. In this experiment, we used the STAMTM Nash/fibrosis-HCC model 
developed by the Japanese company Stelic Institute & Co, Inc. This model is 
created by combining the effect of chemical toxic Streptozotocin (STZ) and 
high fat dietary on non-genetic C57BL/6 mice. It is featured by clear onset of 
NASH and a 100% development of HCC. Specifically, the model is developed 
by giving a low dose STZ injection subcutaneously when mice are two-day 
old, and starting to feed mice with high fat diet when 4 week old. The end 
point for the mice is 20-week old age, during which they will develop NASH, 
fibrosis and HCC finally. Its histological phenotype is quite similar to human 
NASH with peri-sinusoidal fibrosis and fatty lipid droplets accumulation. 
 
 
Figure 5-1. The STAMTM model for NASH-fibrosis/HCC, picture adapted from the 
official website of Stelic Institute & Co, Inc (http://stelic.com/nash/index.html). 
 
In total, 46 cryo-preserved tissue samples have been purchased from the 
company, they are from 6 time points (Table 6-1). Each sample is from one 
mouse. The tissue is not chemically fixed but cryo-frozen preserved directly 
after it is harvested. The samples are then sectioned into 20um thick tissue 
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slides, the tissue is put on quartz glass slides for Raman imaging. Every 
consecutive three sections were separately stained with H&E, Oil Red and 
Sirius Red separately. 
 
Table 5-1. The number of samples in each time point 
Time point Sample number 
Week 4 8 
Week 6 8 
Week 8 8 
Week 12 8 
Week 17 8 
Week 20 6 
 
5.2.2 Raman spectroscope and data acquisition 
The Raman spectroscope is based on the home-built inverted microscope. A 
frequency-doubled Nd: YAG laser with wavelength of 532nm (Millennia 5sJ, 
Spectra-physics) is used as the pump source of a CW tunable Ti: sapphire 
Laser with the wavelength of 785nm (3900S, Spectra-Physics). The collimated 
beam is firstly filtered by the laser line clean-up filter (BPF, LL01-785-12.5, 
Semrock) and directed by a dichroic mirror (LPD01-785RU-25, Semrock) to 
the dual-axis galvanometer mirrors (CT-6210, Cambridge Technology). Then 
the beam size is adjusted by a telescope and focused at the sample plane by the 
water immersion objective lens (Olympus UPLSAPO60XWIR 60X/1.20). 
Laser power at the sample location is around 3.5mW. The 
micrometer-controlled stage realizes the XY position. A piezo actuator 
combined with a differential micrometer (DRV517, Thorlabs) controls the 
course and fine adjustment of the sample focus. The inelastic scattering 
Raman signal is then delivered to the spectrograph (HoloSpec f/1.8i, Kaiser 
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Optical Systems), which is featured by high throughput and low aperture ratio. 
The Raman grating (HSG-785-LF, Kaiser Optical Systems) has the spectra 
shift coverage of -34 to 1894 cm-1 and the spectra resolution of 2.0 cm-1/pixel. 
Spectra are captured by a liquid Nitrogen cooled CCD. An intensity controlled 
white LED is used as the illumination source for the bright field imaging, the 
picture is captured by the CMOS camera (BCN-B050-U, MightTex).  
Labview 8.2 software (National Instruments) and a data acquisition board 
(PCI-6251, National Instruments) are used to control the devices. The setup of 
the system is showed in Figure 5-2. 
 
Figure 5-2. The schematic of home built Raman Spectroscope system. BP: bandpass 
filter. DM: dichroic mirror. 
 
Two types of data have been acquired from the tissue slides. The first type is 
30×30 high resolution spectral images. One image in this type is acquired 
from each tissue sample. This type of data is used for image based analysis. 
The second type is 10×10 low resolution spectral images. Nine images in this 
93 
 
type are acquired from each tissue sample. This type of data is used for 
spectral based analysis. The signal acquisition integral time is 1 sec, therefore 
each 30×30 spectral image would take around 20 minutes to get, each 10×10 
spectral image would take around 2 minutes to get. In the later biochemical 
components analysis, we also acquired the spectra of different chemicals. To 
acquire the spectrum of the basic chemical, small amount of chemical powder 
was put on the quartz cover slip, the resolution was set as 3×3, but since no 
voltage was given to the galvanometer, the nine measurements were actually 
from the same point. The signal acquisition integral time is 10 sec. The spectra 
of basic chemicals were the averaged from the nine measurements.  
 
5.2.3 Data analysis 
The spectra were measured over the range of -175cm-1 to 1843 cm-1, since the 
signal from the quartz substrate is mainly in the range of 250 cm-1 to 580 
cm-1. The spectrum within the range of 600cm-1 to 1800cm-1 is selected for 
analysis. Data processing was performed using MATLAB (Mathworks, 
Massachusetts). The narrow spikes induced by cosmic rays were removed 
firstly, and then fluorescence background from the tissue was estimated and 
subtracted using the adaptive minmax method, the algorithm will be 
introduced in the next section. Finally the spectrum was smoothed before the 
subsequent analysis was performed. 
 
5.2.4 Tissue autofluorescence background subtraction 
Raman spectrum of tissue usually contains Raman scattering, intrinsic tissue 
fluorescence and noise. The removing of tissue background could effectively 
expose the Raman scattering for easier analysis of the basic chemical 
composition of the tissue. In order to achieve the fluorescence background 
subtraction, the method developed by Cao et. al. (194) has been adapted. 
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Based on their method, polynomial fits (195) are used with the consideration 
of the fluorescence-to-signal (F/S) ratio, to minimize the residual mean square 
(RMS) error. Here the F/S ratio is defined as the maximum fluorescence 
divided by the maximum Raman scattering signal, when the minimum 
intensity value is set as zero. The proposed method, named ‘adaptive minmax 
method’, contains two steps, the first step involves constrained and 
unconstrained polynomial fit for two consecutive orders, where the order is 
decided by the adaptive part of the algorithm based on the F/S ratio and can 
also refer to the empiric value listed in Table 5-2; the second step takes the 
maximum value among the initial fits as the points for the final fit. This 
method works better than others with minimized RMS error.  
 
Table 5-2. Orders to be used in constrained/unconstrained polynomial fit 
F/S range Order of fit 
(0, 0.2) 1st,2nd 
(0.2, 0.75) 2nd, 3rd 
(0.75, 8,5) 3rd, 4th 
(8.5, 55) 4th, 5th 
(55, 240) 5th, 6th 
(240, 517) 6th, 7th 
(517, 1000) 7th, 8th 
 
5.2.5 Biological components analysis (BCA) 
The biological components analysis (BCA) is commonly used in Raman 
spectra analysis. The assumption behind this method is that the spectrum of 
tissue is the linear combination of the basic components’ spectra, BCA method 
estimates the contribution of each component by using least square regression. 
This method has been applied in the tissue level study of breast cancer 
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diagnosis (116) and in cell level study of necrotic cells (196). To perform BCA 
analysis, prior knowledge of the constituents of the tissue is required.  
 
For BCA, pure basic biochemical components, including saturated lipid acid, 
unsaturated lipid acid, collagen, glycogen, phenylalanine, NADH and 
3-nitro-L-tyrosine were purchased from Sigma Aldrich (USA) and used 
directly. Raman spectra were measured from each chemical. To decompose the 
spectrum of the tissue, the least square regression method was adapted by 
using a linear curve fitting function lsqnonneg in MATLAB. This function finds 
the non-negative coefficients of all basic component spectra that best fit the 
tissue spectra.  
 
5.2.6 Principle component analysis (PCA) 
The principle component analysis (PCA) method is a non-parametric method 
that uses the orthogonal transformation to convert the data set that possibly 
correlated with each other into the linearly uncorrelated principle components. 
This analysis is widely used in Raman spectroscopy studies of biological 
sample to classify pathological features (197-199), because the classification 
of the spectral data could be easily achieved by choosing different 
combinations of principle components. The purpose of PCA here is to reduce 
the dimensions of a highly complex chemical system to a simpler system that 
has smaller number of principle components. The selected principle 
components effectively contain the important information of the spectra (200). 
However, PCA doesn’t reveal chemically interpretable information of the 
tissue, it provides purely mathematically decomposed information that is 




PCA is performed using princomp function in MATLAB on Raman spectra 
before and after the fluorescence background removal, the background is 
included in the analysis because it may contain important information. Before 
the PCA is preformed, the outliers greater than the 99 percentile were removed, 
the intensity level are standardized across all samples to ensure that all the 





5.3 Results and discussions 
5.3.1 Mean Raman spectra of tissue at different time points 
After the spike signal removal, the spectrum in the range of 600cm-1 to 
1800cm-1 was screened out. The data was carefully reviewed and corrupted 
data was excluded from the further analysis. Here the corrupted data is defined 
when the intensity of the spectrum is beyond the recording range of the 
spectrograph. After the preprocessing the mean Raman spectra of the tissue at 
different time points were plotted. Table 5-3 has listed the number of spectra 
for each time points. 
 
Table 5-3. The number of spectra averaged in each time points 
Time point Sample size 
Week 4 5237 
Week 6 7021 
Week 8 7084 
Week 12 6184 
Week 17 7075 
Week 20 4350 
 
Figure 5-3 shows the typical Raman spectra of the liver tissue at different time 
points. Obviously, the tissue Raman scattering is representing a smaller 
contribution to the intensity, while the intense autofluorescence background is 
quite strong and showing different level among different time points. The peak 
location of the Raman scattering is not changing too much after week 6. The 
difference between week 4 and week 6 onwards is because the diet has 
changed from normal diet to high fat diet from week 4 onwards, while the 
effect of diet change is still negligible when mice are sacrificed in week 4. 
After week 4, the intensity of the Raman scattering is supposed to have been 
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changing, therefore the next step is to remove the tissue fluorescence 
background to reveal the minor changes.  
 
Figure 5-3. Mean spectra of the tissue of each time point. The spectra data have been 
corrected for the spectral response of the system. 
 
Figure 5-4 shows the Raman spectra after the fluorescence background 
substraction as mean ± 1.96SD for six different time points. The variation of 
the overall spectral intensities is relatively higher for week 4 and week 20 
tissue. This is reasonable considering the variability of the individual animal’s 
reaction to the diet changing and producing tumor in the end stage of the 
disease. Besides, within each time points, the variation is relatively small in 





Figure 5-4. Mean Raman spectra after tissue fluorescence background subtraction 
(solid line) ± 1.96SD (shadow area) for tissue of six different time points. 
 
Figure 5-5 displays the mean Raman spectra of six different time points in the 
single plot. Except for the week 4, the spectra of the other time points are 
showing almost identical patterns, most Raman peaks are exactly in the same 
frequency. The reason for big change between week 4 and the rest time points 
has been discussed earlier, which is the effect of the animal dietary change. 
From week 6 onwards, the peaks are exactly in the same frequencies, 
indicating that there should not be new biochemical components generated but 
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only the quantity of the existing components changed with the progression of 
the disease. 
 
Figure 5-5. Mean Raman spectra after tissue fluorescence background subtraction in a 
single plot. Except for week 4, the spectra of the other five time points display almost 
identical patterns. The main peaks are all in the same frequency. 
 
5.3.2 Selection of basic chemical components 
Table 5-4 lists the basic biochemical components chosen for analysis. The 
reasons of selection are also listed in the table.  
 




1 Oleic acid unsaturated fatty acid 
2 Palmitic acid Saturated fatty acid 
3 Collagen (type I, II, III) Main component inside liver, would increase 
quantity with fibrosis 
4 Glycogen Main form of energy storage 
5 phenylalanine Amino acid to form proteins 
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6 NADP/NADPH Coenzyme in all living cells responsible for 
metabolism 
7 3-nitro-L-tyrosine Indicator of cell damage 
 
Figure 5-6 shows the Raman spectra of the selected basic biochemical 
components. The spectra of oleic acid and palmitic acid are quite similar to the 
spectrum of liver tissue; it indicates the dominant role of the fatty acid in the 
liver with NAFLD. Oleic acid is a mono-unsaturated acid, which means it has 
only one double bound (C=C) in the fatty acid. During the experiment, we also 
measure the Raman spectrum of linoleic acid, which is a polyunsaturated acid, 
but the spectra of the two chemicals are identical (data is not show). Oleic 
acid’s spectrum is featured by the peaks at 1266 cm-1 and 1655 cm-1, both of 
them are corresponding to the double bond (C=C). Palmitic acid is featured by 
the peak at 1302 cm-1 and 1446 cm-1 (201). These two peaks are attributed to 
CH2 stretching mode. The Phenylalanine is featured by the peak at 1004 cm-1 
corresponding to the C-C stretching (202). The captured peak at 830 cm-1 of 





Figure 5-6. The Raman spectra of selected basic chemical components. These 




5.3.3 Biological component analysis result 
Figure 5-7 shows the average Raman spectra of the liver tissue from different 
time points of NAFLD and the fitting results to the combination of selected 
basic biochemical components. The fitting result is represented in cyan color, 
the fitting residue is showed in red color. The fitting coefficient is shown in the 
Table 5-5, the fitting coefficients are normalized to sum to one. The coefficient 
of unsaturated fatty acid and saturated fatty acid are summed, the coefficient 
of collagen type I, II and III are also summed for easier discussion. 
 
From the result, the change of fat components is the most obvious. From week 
4 to week 6 the percentage of fat is increasing obviously. This can be 
explained by the changing of diet from common diet to high fat diet. The 
percentage of the collagen is also increasing, but the changing amplitude is not 
big and it remains unchanged in the later stage. This finding is consistent with 
our UV imaging of collagen and Sirus red staining of collagen, therefore the 
tissue is not much fiber condensed in the late stage in this animal model. The 
glycogen representing the polysaccharides inside the tissue is the second main 
form of energy storage besides fat, but since it has relatively lower energy  
 














Fat Fat droplets 50 67 65 66 60 60 
Collagen fibrosis 14 16 15.7 17 16 17 
glycogen Energy storage 5 0 2.1 0.8 0.8 1.8 
Phenylalanine cancer 14 7 6.5 6 8 7.2 
NADH metabolites 3 0 1.9 0.2 1.2 2 
104 
 
tyrosine NO-derived oxidant 14 10 9.3 10 14 12 
*The fitting coefficients are normalized to the sum to one, and represented in percentage form  
 
 
Figure 5-7. The mean Raman spectra of tissue at different time points and the 
corresponding fitting results. The line of blue color is the original spectrum, while the 
line of cyan color is the fitting result. The red color line is the fitting residue. 
105 
 
storage efficiency comparing to fat, so the amount of glycogen is lower than 
fat in liver. The amount of glycogen has decreased drastically from the week 4 
indicate diseased liver tissue has lower metabolic ability. The NADH is not 
changing too much, we speculate the reason of this is that frozen preserving is 
not good for keeping NADH inside the tissue, so that NADH has largely 
vanished.   
 
5.3.4 Principle component analysis result 
The accumulated variance explained by the first 10 principle components (PC) 
is plotted in Figure 5-8. From the analysis, PC1 already accounts for the most 
variance (around 99.6%) in the data set. The first five PCs have achieved an 
accumulated variance up to100%. 
 
Figure 5-8. The accumulated variance explained by the first 10 PCs 
 
The 2D and 3D plots of different combination of first five PCs are displayed in 
Figure 5-9. It was found that the combination of first PC has the most ability 
to differentiate the data set of different time points. However, the others don’t 
show much ability in differentiating data. Referring back to the raw spectra of 
the tissue in Figure 5-3, the raw spectra of different time points shows 
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different magnitude. For PCA analysis, unless the vectors in the dataset are 
completely normalized, the top PC is typically a global shift of magnitude. 
This explains the great variance interpretation ability of PC1. 
 
Figure 5-9. The 2D and 3D plot of different combinations of first five PCs 
 
The loading of the first three principle components in PCA is shown in Figure 
5-10. It was found that PC1 is much flat and it can be explained the global 
magnitude of the data, it can also be explained as the fluorescence background 
of the data set. PC2 is glass background signal caused by back-reflected 
Rayleigh light. PC3 resembles the spectrum of fatty acid (referring back to 
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Figure 5-6). This result indicates the dominant role of fatty acid in the 
progression of NAFLD.  
 








Raman spectroscopy provides a unique advantage in studying the fatty liver 
disease. Understanding the chemical basis of the Raman spectrum of the liver 
tissue with progressing NAFLD is necessarily important in developing the 
disease mechanism model for the future research. In this chapter, we described 
the experiment that used the near-infrared Raman spectroscopy to measure the 
spectra of liver tissue at six different time points. The Raman spectra with or 
without the fluorescence background is plotted. The data was analyzed by 
decomposing the tissue to the basic biochemical components using least 
square regression. The results show the clear increasing of fatty acid 
components. Principle components analysis was also used to identify the 
dominant differentiating factor within the dataset. The result also indicates the 
dominant role of fatty acid. We, hereby, acknowledge the important role of 
fatty acid accumulation during the progression of NAFLD. However, some 
data requires further analysis and careful scrutinizing to reveal the underlying 




Chapter 6 Conclusion and recommendations for 
future research 
6.1 Summary  
This thesis described the study of imaging marker from liver surface during 
the chronic liver disease progression using different optical microscopic 
techniques. The hypothesis that drives the whole thesis study is that the 
hepatic microcirculation is a meaningful marker for liver disease, and drives 
the progression of the disease. Chronic liver disease can be composed of 
complex histological spectra, such as inflammation, fibrosis and steatosis. In 
this thesis, the study focuses on two different histological spectra of chronic 
liver disease: fibrosis and steatosis.  
 
The first part starts from the design and development of the intra-vital imaging 
window for liver in vivo imaging. With a highly reproducible liver fibrosis 
animal model, we established a quantified method to characterize the change 
of hepatic microcirculation during the fibrotic disease and correlated the 
changes with the staging of the fibrosis. We discovered that the drastic change 
of the hepatic microcirculation takes place in the early to middle stage of the 
fibrosis. From this result, we infer that the microcirculation lesion drives the 
progression of fibrosis by preceding the changes of the other features such as 
collagen accumulation.  
 
In order to quantitatively denote the disease progression, we keep on looking 
for structural features of liver surface that relate to hepatic fibrotic status. On 
the same fibrosis model, images were taken from the liver of both normal rats 
and end stage fibrotic rats using nonlinear microscope. Five features regarding 
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the collagen, elastin morphology and redox status of hepatocytes were 
extracted and quantified. We found that they are significantly different 
between the normal and fibrotic group.  
 
In the third part of the study, we shift our attention to the non-alcoholic fatty 
liver disease (NAFLD) because NAFLD has become the main driver for the 
increased prevalence of chronic liver disease worldwide. NAFLD is a chronic 
liver disease that involves multiple spectra of liver pathology, including 
hepatic steatosis, necroinflammation, fibrosis. Its complication includes 
advanced cirrhosis and HCC. In this part we focus on steatosis mainly and 
delineated the structural feature changes with Raman micro-spectroscopy, and 
find that fatty acid is playing a dominant role in the progression of the disease. 
The exact mechanism behind requires further experiment and analysis.  
 
To conclude, this study focus on searching for imaging markers that are 
potentially useful to monitor the liver disease. With further study on this topic, 
we envision the integration of all the imaging markers and the comparison of 
the significant onset of structural feature change and the microcirculation 
feature change to further prove the hypothesis about the importance of 
microcirculation.  
 
6.2 Recommendations for future research 
In chapter 4, we have demonstrated that the hepatocytes redox status obtained 
from two photon images is changing with the liver disease status. In the 
literature searching, we also find that the redox status could also be related to 
the hepatic inflammation (186, 204). To demonstrate this hypothesis, further 




As we have already known, BDL surgery created a well-established 
experimental extrahepatic cholestasis animal model. The early stage of 
extrahepatic cholestasis disease is featured by hepatic inflammation (205, 206). 
During the early phase after BDL, Kupffer cells are activated by showing 
increased phagocytic activity, cytokines formation and platelet activating 
factor formation one week after BDL (207-209). Therefore the early stage of 
BDL animal provides a good animal model of investigating hepatic 
inflammation. Using the redox ratio to monitor the early stage of the BDL 
model, we could probably have interesting findings.   
 
In chapter 5, the biochemical components feature change of steatosis has been 
delineated with Raman micro-spectroscopy. With large amount of data 
acquired, the study requires further analysis to reveal the mechanism of the 
progression of NAFLD on this animal model. The statistical model of the 
disease progression can be created by feeding the features extracted from PCA 
and BCA analysis into a linear discriminant classifier to train the classifier. 
Further evaluating the classification accuracy and comparison between the two 
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